Case number 1:17-cv-00868
University of Massachusetts et al v. L'Oreal U.S.A., Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 15, 2024 | 433 | SO ORDERED, re 432 Stipulation of Dismissal with Prejudice. (***Civil Case Terminated). Signed by Judge Jennifer L. Hall on 4/15/2024. (ceg) (Entered: 04/15/2024) (2) |
| Apr 15, 2024 | 434 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,423,327 B1; US 6,423,327 B1. (Attachments: # 1 Stipulation of Dismissal)(ceg) (Entered: 04/15/2024) (0) |
| Apr 12, 2024 | 432 | STIPULATION of Dismissal by Carmel Laboratories, LLC. (Farnan, Brian) (Entered: 04/12/2024) (2) |
| Apr 9, 2024 | 431 | ORAL ORDER: IT IS HEREBY ORDERED that the parties shall file a stipulation of dismissal or a joint status report on or before April 12, 2024. Ordered by Judge Jennifer L. Hall on 4/9/2024. (ceg) (Entered: 04/09/2024) (0) |
| Apr 5, 2024 | 430 | STATUS REPORT by University of Massachusetts. (Farnan, Brian) (Entered: 04/05/2024) (2) |
| Mar 25, 2024 | 429 | ORAL ORDER: IT IS HEREBY ORDERED that the parties shall file a stipulation of dismissal or a joint status report on or before April 5, 2024. Ordered by Judge Jennifer L. Hall on 3/25/2024. (ceg) (Entered: 03/25/2024) (0) |
| Mar 22, 2024 | 428 | Joint STATUS REPORT, by L'Oreal USA, Inc. (Mowery, Katharine) Modified on 3/22/2024 (ceg). (Entered: 03/22/2024) (2) |
| Mar 5, 2024 | 427 | SO ORDERED, re 426 Joint Status Report and Order. The parties will file a Stipulation of Dismissal or Updated Joint Status Report on or before March 22, 2024. Signed by Judge Jennifer L. Hall on 3/5/2024. (ceg) (Entered: 03/05/2024) (2) |
| Mar 4, 2024 | 426 | Joint STATUS REPORT by L'Oreal USA, Inc.. (Mowery, Katharine) (Entered: 03/04/2024) (2) |
| Mar 1, 2024 | 425 | SO ORDERED, re 424 Stipulation and Order to Extend Time to submit a joint status report to March 4, 2024. (*Resetting Deadlines: Status Report due by 3/4/2024). Signed by Judge Jennifer L. Hall on 3/1/2024. (ceg) (Entered: 03/01/2024) (1) |
| Feb 29, 2024 | 424 | STIPULATION TO EXTEND TIME to Submit Joint Status Report to March 4, 2024 - filed by L'Oreal USA, Inc.. (Mowery, Katharine) (Entered: 02/29/2024) (1) |
| Feb 23, 2024 | 423 | SO ORDERED, re 422 Stipulation and Order to Extend Time for the parties to submit a joint status report to February 29, 2024. (*Resetting Deadlines: Status Report due by 2/29/2024). Signed by Judge Jennifer L. Hall on 2/23/2024. (ceg) (Entered: 02/23/2024) (1) |
| Feb 22, 2024 | 422 | STIPULATION TO EXTEND TIME to Submit Status Report to February 29, 2024 - filed by Carmel Laboratories, LLC. (Farnan, Brian) (Entered: 02/22/2024) (1) |
| Feb 15, 2024 | 420 | STIPULATION TO EXTEND TIME for the parties to submit a joint status report to February 22, 2024 - filed by L'Oreal USA, Inc.. (Mowery, Katharine) (Entered: 02/15/2024) (1) |
| Feb 15, 2024 | 421 | SO ORDERED, re 420 Stipulation and Order to Extend Time for the parties to submit a joint status report to February 22, 2024. (*Resetting Deadlines: Status Report due by 2/22/2024). Signed by Judge Jennifer L. Hall on 2/15/2024. (ceg) (Entered: 02/15/2024) (1) |
| Feb 8, 2024 | 419 | ORAL ORDER: This case is among the hundreds of cases recently reassigned to me. The docket suggests that there has been no case activity since the Federal Circuit's August 2022 Mandate. (D.I. 418 (reversing in part, vacating in part, and remanding.) On or before February 15, 2024, the parties shall meet and confer and file a joint status letter setting forth their position(s) on how this case should proceed. Ordered by Judge Jennifer L. Hall on 2/8/2024. (ceg) (Entered: 02/08/2024) (0) |
| Aug 5, 2022 | 418 | USCA Mandate (Main Document) (1) Docket Text: MANDATE of USCA as to [416] Notice of Appeal (Federal Circuit), filed by University of Massachusetts, Carmel Laboratories, LLC. USCA Decision: REVERSED IN PART, VACATED IN PART, AND REMANDED. (Attachments: # (1) Judgment, # (2) Opinion)(kmd) |
| Aug 5, 2022 | 418 | USCA Mandate (Judgment) (1) Docket Text: MANDATE of USCA as to [416] Notice of Appeal (Federal Circuit), filed by University of Massachusetts, Carmel Laboratories, LLC. USCA Decision: REVERSED IN PART, VACATED IN PART, AND REMANDED. (Attachments: # (1) Judgment, # (2) Opinion)(kmd) |
| Aug 5, 2022 | 418 | USCA Mandate (Opinion) (19) Docket Text: MANDATE of USCA as to [416] Notice of Appeal (Federal Circuit), filed by University of Massachusetts, Carmel Laboratories, LLC. USCA Decision: REVERSED IN PART, VACATED IN PART, AND REMANDED. (Attachments: # (1) Judgment, # (2) Opinion)(kmd) |
| May 20, 2021 | 417 | USCA Notice of Docketing ROA (4) Docket Text: NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [416] Notice of Appeal (Federal Circuit), filed by University of Massachusetts, Carmel Laboratories, LLC. USCA Case Number 2021-1969. (nmf) |
| May 14, 2021 | N/A | APPEAL - Credit Card Payment (0) Docket Text: APPEAL - Credit Card Payment of $505.00 received re [416] Notice of Appeal (Federal Circuit), filed by University of Massachusetts, Carmel Laboratories, LLC. ( Filing fee $505, receipt number ADEDC-3615993.) (Farnan, Brian) |
| May 14, 2021 | N/A | Appeal Notification to Reporter Gunning (0) Docket Text: Notification regarding [416] Notice of Appeal (Federal Circuit), sent to Reporter Gunning. (kmd) |
| May 14, 2021 | N/A | Notice of Appeal and Docket Sheet to USCA (0) Docket Text: Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re [416] Notice of Appeal (Federal Circuit). (kmd) |
| May 14, 2021 | 414 | Judgment (2) Docket Text: FINAL JUDGMENT in favor of L'Oreal USA, Inc. against Carmel Laboratories, LLC, University of Massachusetts (CASE CLOSED). Signed by Judge Colm F. Connolly on 5/14/2021. (nmf) |
| May 14, 2021 | 415 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,423,327 B1 ;US 6,645,513 B2. (Attachments: # (1) Judgment)(nmf) |
| May 14, 2021 | 415 | Judgment (2) |
| May 14, 2021 | 416 | Notice of Appeal (Federal Circuit) (3) Docket Text: NOTICE OF APPEAL to the Federal Circuit of [411] Order on Motion for Summary Judgment, [414] Judgment, [36] Memorandum and Order, Order Adopting Report and Recommendations, Order on Motion to Dismiss, Order on Motion to Dismiss/Failure to State Claim, Order on Report and Recommendations, . Appeal filed by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| May 14, 2021 | 416 | Notice of Appeal* (1) |
| May 14, 2021 | N/A | Description not available (0) Docket Text: Notification regarding [416] Notice of Appeal (Federal Circuit), sent to Reporter Gunning. (kmd) |
| May 14, 2021 | 415 | Patent/Trademark Report to Commissioner (Main Document) (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,423,327 B1 ;US 6,645,513 B2. (Attachments: # (1) Judgment)(nmf) |
| May 14, 2021 | 415 | Patent/Trademark Report to Commissioner (Judgment) (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,423,327 B1 ;US 6,645,513 B2. (Attachments: # (1) Judgment)(nmf) |
| May 12, 2021 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 5/12/2021. (Court Reporter V. Gunning.) Counsel to submit a revised proposed judgment to the Court on or before May 13, 2021. (nmf) |
| May 12, 2021 | 413 | Proposed Order (2) Docket Text: PROPOSED ORDER Final Judgment by Carmel Laboratories, LLC. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Farnan, Brian) |
| May 12, 2021 | 413 | Letter to The Honorable Colm F. Connolly (1) |
| May 12, 2021 | 413 | Proposed Order (Main Document) (2) Docket Text: PROPOSED ORDER Final Judgment by Carmel Laboratories, LLC. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Farnan, Brian) |
| May 12, 2021 | 413 | Proposed Order (Letter to The Honorable Colm F. Connolly) (1) Docket Text: PROPOSED ORDER Final Judgment by Carmel Laboratories, LLC. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Farnan, Brian) |
| May 7, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER Setting Teleconference: Counsel for Plaintiffs to coordinate the call and email the dial-in information to chambers. A Telephone Conference is set for 5/12/2021 at 09:30 AM before Judge Colm F. Connolly to discuss the proposed judgment. Ordered by Judge Colm F. Connolly on 5/7/2021. (nmf) |
| May 6, 2021 | 412 | Proposed Order (2) Docket Text: PROPOSED ORDER Proposed Final Judgment by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Farnan, Brian) |
| May 6, 2021 | 412 | Letter to The Honorable Colm F. Connolly (1) |
| May 6, 2021 | 412 | Proposed Order (Main Document) (2) Docket Text: PROPOSED ORDER Proposed Final Judgment by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Farnan, Brian) |
| May 6, 2021 | 412 | Proposed Order (Letter to The Honorable Colm F. Connolly) (1) Docket Text: PROPOSED ORDER Proposed Final Judgment by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Farnan, Brian) |
| May 5, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Per the conversation with counsel during the telephonic hearing on April 26, 2021, IT IS ORDERED that all pending motions are denied as moot, the June 21, 2021 jury trial is CANCELED, and on or before Monday, May 10, 2021, counsel shall submit a proposed judgment to the Court. Ordered by Judge Colm F. Connolly on 5/5/2021. (nmf) |
| Apr 26, 2021 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 4/26/2021. (Court Reporter V. Gunning.) Counsel to submit a proposed judgment to the Court. (nmf) |
| Apr 21, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER Setting Telephonic Status Conference: Counsel for Plaintiffs to coordinate the call and email the dial-in information to chambers.( A Telephone Conference is set for 4/26/2021 at 02:00 PM before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 4/21/2021. (nmf) |
| Apr 20, 2021 | 410 | Memorandum Opinion (15) Docket Text: MEMORANDUM OPINION Signed by Judge Colm F. Connolly on 4/20/2021. (nmf) |
| Apr 20, 2021 | 411 | Order on Motion for Summary Judgment (1) Docket Text: ORDER that D.I. [278] Motion for Summary Judgment is GRANTED and that claims 1, 3, 5, 6, 7, and 9 of U.S. Patent Nos. 6,423,327 and 6,645,513 are INVALID. Signed by Judge Colm F. Connolly on 4/20/2021. (nmf) |
| Feb 18, 2021 | 409 | Redacted Document (28) Docket Text: REDACTED VERSION of [406] Proposed Pretrial Order, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-10, # (2) Exhibits 11-14, # (3) Exhibits 15-16, # (4) Exhibits 17-19)(Farnan, Brian) |
| Feb 18, 2021 | 409 | Exhibits 1-10 (491) |
| Feb 18, 2021 | 409 | Exhibits 11-14 (207) |
| Feb 18, 2021 | 409 | Exhibits 15-16 (276) |
| Feb 18, 2021 | 409 | Exhibits 17-19 (283) |
| Feb 18, 2021 | 409 | Redacted Document (Main Document) (28) Docket Text: REDACTED VERSION of [406] Proposed Pretrial Order, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-10, # (2) Exhibits 11-14, # (3) Exhibits 15-16, # (4) Exhibits 17-19)(Farnan, Brian) |
| Feb 18, 2021 | 409 | Redacted Document (Exhibits 1-10) (30) Docket Text: REDACTED VERSION of [406] Proposed Pretrial Order, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-10, # (2) Exhibits 11-14, # (3) Exhibits 15-16, # (4) Exhibits 17-19)(Farnan, Brian) |
| Feb 18, 2021 | 409 | Redacted Document (Exhibits 11-14) (30) Docket Text: REDACTED VERSION of [406] Proposed Pretrial Order, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-10, # (2) Exhibits 11-14, # (3) Exhibits 15-16, # (4) Exhibits 17-19)(Farnan, Brian) |
| Feb 18, 2021 | 409 | Redacted Document (Exhibits 15-16) (30) Docket Text: REDACTED VERSION of [406] Proposed Pretrial Order, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-10, # (2) Exhibits 11-14, # (3) Exhibits 15-16, # (4) Exhibits 17-19)(Farnan, Brian) |
| Feb 18, 2021 | 409 | Redacted Document (Exhibits 17-19) (30) Docket Text: REDACTED VERSION of [406] Proposed Pretrial Order, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-10, # (2) Exhibits 11-14, # (3) Exhibits 15-16, # (4) Exhibits 17-19)(Farnan, Brian) |
| Feb 12, 2021 | 408 | SO ORDERED (1) Docket Text: SO ORDERED, re [407] STIPULATION TO EXTEND TIME to File Redactions to Joint Pretrial Order to February 18, 2021 filed by L'Oreal USA, Inc. Signed by Judge Colm F. Connolly on 2/12/2021. (nmf) |
| Feb 11, 2021 | 407 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to File Redactions to Joint Pretrial Order to February 18, 2021 - filed by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Feb 4, 2021 | 401 | Proposed Voir Dire (8) Docket Text: Proposed Voir Dire by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Feb 4, 2021 | 402 | Proposed Jury Instructions (30) Docket Text: Proposed Jury Instructions by Carmel Laboratories, LLC, University of Massachusetts Joint Proposed Preliminary Jury Instructions. (Farnan, Brian) |
| Feb 4, 2021 | 403 | Proposed Jury Instructions (30) Docket Text: Proposed Jury Instructions by Carmel Laboratories, LLC, University of Massachusetts Joint Proposed Final Jury Instructions. (Farnan, Brian) |
| Feb 4, 2021 | 404 | Verdict Sheet (9) Docket Text: VERDICT SHEET by Carmel Laboratories, LLC, University of Massachusetts Plaintiffs' Proposed Verdict Form. (Farnan, Brian) |
| Feb 4, 2021 | 405 | Verdict Sheet (10) Docket Text: VERDICT SHEET by L'Oreal USA, Inc. . (Mowery, Katharine) |
| Jan 27, 2021 | 400 | Order Setting Mediation Conferences (7) Docket Text: ORDER Setting Mediation Conference: A Mediation Conference is set for 2/16/2021 at 10:00 AM before Judge Christopher J. Burke. To the extent the attached Order refers to an in-person appearance, the parties' participation shall be via telephone or via video conference. Counsel shall e-mail Deborah Benyo the Confidential Mediation statements by February 9, 2021 and provide the Court with the names of all participants and the appropriate video conference links including a joint link for mediation orientation or dial-in information by no later than the due date of the Confidential Mediation Statements. Signed by Judge Christopher J. Burke on 1/27/2021. (dlb) |
| Jan 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [399] STIPULATION TO EXTEND TIME for the parties to file their Joint Pretrial Order and to submit jury instructions, voir dire and special verdict forms to February 4, 2021 filed by L'Oreal USA, Inc. Ordered by Judge Colm F. Connolly on 1/19/2021. (fms) |
| Jan 15, 2021 | 399 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to file their Joint Pretrial Order and to submit jury instructions, voir dire and special verdict forms to February 4, 2021 - filed by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Jan 11, 2021 | 398 | Order Setting Mediation Conferences (5) Docket Text: ORDER Setting Mediation Conference: A Telephone Conference is set for 1/25/2021 at 10:00 AM before Judge Christopher J. Burke. By no later than January 22, 2021, the parties shall jointly provide the Court's Courtroom Deputy, Ms. Benyo, with a dial-in number via e-mail to use for the call. Signed by Judge Christopher J. Burke on 1/11/21. (dlb) |
| Jan 7, 2021 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 1/7/2021. (Court Reporter V. Gunning.) (nmf) |
| Jan 7, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER Re-Setting Scheduling Order Deadlines: The Final Pretrial Conference is rescheduled for 6/9/2021 at 04:00 PM in Courtroom 4B before Judge Colm F. Connolly., The Jury Trial is rescheduled for 6/21/2021 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 1/7/2021. (nmf) |
| Dec 22, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [397] Letter, ORDER Setting Teleconference: Counsel for Defendant to coordinate the call and email the dial-in information to chambers.( A Telephone Conference is set for 1/7/2021 at 03:30 PM before Judge Colm F. Connolly), ORDER,terminating Hearings: The 2/8/2021 Jury Trial is postponed. A new jury trial date will be discussed during the 1/7/2021 telephone conference. All remaining deadlines, including the 1/25/2021 proposed pretrial order deadline shall remain in place. Ordered by Judge Colm F. Connolly on 12/22/2020. (nmf) |
| Dec 21, 2020 | 397 | Letter (2) Docket Text: Letter to The Honorable Colm F.Connolly from Frederick L. Cottrell, III regarding the trial date. (Cottrell, Frederick) |
| Dec 14, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [396] MOTION for Pro Hac Vice Appearance of Attorney Robert Unikel filed by L'Oreal USA, Inc. Signed by Judge Colm F. Connolly on 12/14/2020. (fms) |
| Dec 11, 2020 | 396 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Robert Unikel - filed by L'Oreal USA, Inc.. Motions referred to Sherry R. Fallon.(Mowery, Katharine) |
| Nov 20, 2020 | 395 | Reply Brief (15) Docket Text: REPLY BRIEF re [392] Cross MOTION to Submit the Expert Report of Dr. Ryan Cheu filed by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Nov 13, 2020 | 394 | Reply Brief (15) Docket Text: REPLY BRIEF re [392] Cross MOTION to Submit the Expert Report of Dr. Ryan Cheu [L'Oreal USA's Reply Brief in Support of its Rule 56(c)(2) Objections to, and Request to Strike, Plaintiffs' New Expert Disclosed for the First Time in Their Reply Brief and Opposition to Plaintiffs' Conditional Cross-Motion] filed by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Cottrell, Frederick) |
| Nov 13, 2020 | 394 | Certificate of Compliance (1) |
| Nov 13, 2020 | 394 | Reply Brief (Main Document) (15) Docket Text: REPLY BRIEF re [392] Cross MOTION to Submit the Expert Report of Dr. Ryan Cheu [L'Oreal USA's Reply Brief in Support of its Rule 56(c)(2) Objections to, and Request to Strike, Plaintiffs' New Expert Disclosed for the First Time in Their Reply Brief and Opposition to Plaintiffs' Conditional Cross-Motion] filed by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Cottrell, Frederick) |
| Nov 13, 2020 | 394 | Reply Brief (Certificate of Compliance) (1) Docket Text: REPLY BRIEF re [392] Cross MOTION to Submit the Expert Report of Dr. Ryan Cheu [L'Oreal USA's Reply Brief in Support of its Rule 56(c)(2) Objections to, and Request to Strike, Plaintiffs' New Expert Disclosed for the First Time in Their Reply Brief and Opposition to Plaintiffs' Conditional Cross-Motion] filed by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Cottrell, Frederick) |
| Nov 6, 2020 | N/A | Motions No Longer Referred (0) Docket Text: Motions No Longer Referred: [392] Cross MOTION to Submit the Expert Report of Dr. Ryan Cheu. The automatic referral generated by the system has been removed for this motion. (nmf) |
| Nov 6, 2020 | 392 | Motion for Miscellaneous Relief (3) Docket Text: Cross MOTION to Submit the Expert Report of Dr. Ryan Cheu - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)(Farnan, Brian) Modified on 11/9/2020 (nmf). |
| Nov 6, 2020 | 392 | Text of Proposed Order (1) |
| Nov 6, 2020 | 393 | Statement (21) Docket Text: STATEMENT re [392] Cross MOTION to Submit the Expert Report of Dr. Ryan Cheu , [372] Objections, Plaintiffs' Opposition to L'Oreal's Motion to Strike and Opening Brief in Support of Conditional Cross-Motion to Submit The Expert Report of Dr. Ryan Cheu by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Nov 6, 2020 | N/A | Motions No Longer Referred (0) Docket Text: Motions No Longer Referred: [392] Cross MOTION to Submit the Expert Report of Dr. Ryan Cheu. The automatic referral generated by the system has been removed for this motion. (nmf) |
| Nov 6, 2020 | 392 | Motion for Miscellaneous Relief (Main Document) (3) Docket Text: Cross MOTION to Submit the Expert Report of Dr. Ryan Cheu - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)(Farnan, Brian) Modified on 11/9/2020 (nmf). |
| Nov 6, 2020 | 392 | Motion for Miscellaneous Relief (Text of Proposed Order) (1) Docket Text: Cross MOTION to Submit the Expert Report of Dr. Ryan Cheu - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)(Farnan, Brian) Modified on 11/9/2020 (nmf). |
| Oct 30, 2020 | 391 | Redacted Document (8) Docket Text: REDACTED VERSION of [372] Objections, by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Certificate of Compliance, # (4) 7.1.1 Statement)(Mowery, Katharine) |
| Oct 30, 2020 | 391 | Text of Proposed Order (2) |
| Oct 30, 2020 | 391 | Exhibit A (2) |
| Oct 30, 2020 | 391 | Certificate of Compliance (1) |
| Oct 30, 2020 | 391 | 7.1.1 Statement (1) |
| Oct 30, 2020 | 391 | Redacted Document (Main Document) (8) Docket Text: REDACTED VERSION of [372] Objections, by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Certificate of Compliance, # (4) 7.1.1 Statement)(Mowery, Katharine) |
| Oct 30, 2020 | 391 | Redacted Document (Text of Proposed Order) (2) Docket Text: REDACTED VERSION of [372] Objections, by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Certificate of Compliance, # (4) 7.1.1 Statement)(Mowery, Katharine) |
| Oct 30, 2020 | 391 | Redacted Document (Exhibit A) (2) Docket Text: REDACTED VERSION of [372] Objections, by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Certificate of Compliance, # (4) 7.1.1 Statement)(Mowery, Katharine) |
| Oct 30, 2020 | 391 | Redacted Document (Certificate of Compliance) (1) Docket Text: REDACTED VERSION of [372] Objections, by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Certificate of Compliance, # (4) 7.1.1 Statement)(Mowery, Katharine) |
| Oct 30, 2020 | 391 | Redacted Document (7.1.1 Statement) (1) Docket Text: REDACTED VERSION of [372] Objections, by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Certificate of Compliance, # (4) 7.1.1 Statement)(Mowery, Katharine) |
| Oct 26, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED- re [374] MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler. Signed by Judge Sherry R. Fallon on 10/26/2020. (lih) |
| Oct 26, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Per request of Counsel, the Request for Oral Argument at D.I. [373] has been linked to the Objections at D.I. [372] as the system would not allow counsel to link this entry. The text has also been updated. (nmf) |
| Oct 26, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Bruce M. Wexler for L'Oreal USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Oct 23, 2020 | 373 | Request for Oral Argument (3) Docket Text: REQUEST for Oral Argument by L'Oreal USA, Inc. re [265] MOTION for Partial Summary Judgment on Enablement, [274] MOTION for Summary Judgment of Indefiniteness of the Dermal Cell Adenosine Concentration Claim Limitation, [268] MOTION to Preclude Untimely and Irrelevant Opinions Regarding Damages, [262] MOTION for Partial Summary Judgment of Non-Obviousness, [259] MOTION for Partial Summary Judgment of No Anticipation, [278] MOTION for Summary Judgment of Indefiniteness of the Skin Enhancement Claim Limitation, [256] MOTION to Strike Untimely Invalidity Theories and References, [277] MOTION No. 5: L'Oreal USA, Inc.'s Motion to Exclude Certain Opinions of Ms. Julie Davis , [271] MOTION to Preclude Irrelevant Opinions About Inventor Declarations to the PTO, [283] MOTION for Summary Judgment of Anticipation, [281] MOTION No. 4: L'Oreal USA, Inc.'s Motion to Exclude Expert Opinions Related to Dr. Kisak's Testing, [372] [SEALED] OBJECTIONS by L'Oreal USA, Inc. to 355 Statement, [Rule 56(C)(2) Objections to, and Request to Strike, Plaintiffs' New Expert Disclosed for the First Time in Their Reply Brief] . (Mowery, Katharine) Modified on 10/26/2020 (nmf). |
| Oct 23, 2020 | 374 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler - filed by L'Oreal USA, Inc.. Motions referred to Sherry R. Fallon.(Cottrell, Frederick) |
| Oct 23, 2020 | 375 | Redacted Document (13) Docket Text: REDACTED VERSION of [354] Reply Brief by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Oct 23, 2020 | 376 | Redacted Document (30) Docket Text: REDACTED VERSION of [355] Statement, by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Oct 23, 2020 | 377 | Redacted Document (11) Docket Text: REDACTED VERSION of [356] Reply Brief by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Oct 23, 2020 | 378 | Redacted Document (8) Docket Text: REDACTED VERSION of [357] Reply Brief by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Oct 23, 2020 | 379 | Redacted Document (10) Docket Text: REDACTED VERSION of [359] Statement, by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Oct 23, 2020 | 380 | Redacted Document (6) Docket Text: REDACTED VERSION of [360] Reply Brief by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Oct 23, 2020 | 381 | Redacted Document (11) Docket Text: REDACTED VERSION of [363] Reply Brief by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Oct 23, 2020 | 382 | Redacted Document (29) Docket Text: REDACTED VERSION of [366] Statement, by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Oct 23, 2020 | 383 | Redacted Document (22) Docket Text: REDACTED VERSION of [367] Reply Brief by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Oct 23, 2020 | 384 | Redacted Document (30) Docket Text: REDACTED VERSION of [368] Declaration by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Oct 23, 2020 | 385 | Redacted Document (15) Docket Text: REDACTED VERSION of [358] Reply Brief by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Oct 23, 2020 | 386 | Redacted Document (8) Docket Text: REDACTED VERSION of [361] Reply Brief by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Oct 23, 2020 | 387 | Redacted Document (13) Docket Text: REDACTED VERSION of [362] Reply Brief, by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Oct 23, 2020 | 388 | Redacted Document (14) Docket Text: REDACTED VERSION of [364] Reply Brief by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Oct 23, 2020 | 389 | Redacted Document (14) Docket Text: REDACTED VERSION of [365] Reply Brief by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Oct 23, 2020 | 390 | Redacted Document (5) Docket Text: REDACTED VERSION of [369] Declaration by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit 39-49)(Mowery, Katharine) |
| Oct 23, 2020 | 390 | Exhibit 39-49 (89) |
| Oct 23, 2020 | 390 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [369] Declaration by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit 39-49)(Mowery, Katharine) |
| Oct 23, 2020 | 390 | Redacted Document (Exhibit 39-49) (30) Docket Text: REDACTED VERSION of [369] Declaration by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit 39-49)(Mowery, Katharine) |
| Oct 22, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Per request of filer, the Notice of Change of Firm Name at D.I. [370] has been removed and replaced and the docket text has been corrected (fms) |
| Oct 22, 2020 | 371 | Order (2) Docket Text: ORDER OVERRULING [253] Objections, filed by University of Massachusetts, Carmel Laboratories, LLC. Signed by Judge Colm F. Connolly on 10/22/2020. (nmf) |
| Oct 21, 2020 | 370 | Notice of Change of Address (2) Docket Text: NOTICE of Change of Firm Name by Katharine Lester Mowery (Mowery, Katharine) Modified on 10/22/2020 (fms). (Main Document 370 replaced on 10/22/2020) (fms). |
| Oct 9, 2020 | 332 | Redacted Document (20) Docket Text: REDACTED VERSION of [310] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Oct 9, 2020 | 333 | Redacted Document (30) Docket Text: REDACTED VERSION of [311] Statement, by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Oct 9, 2020 | 334 | Redacted Document (19) Docket Text: REDACTED VERSION of [312] Answering Brief in Opposition, by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Oct 9, 2020 | 335 | Redacted Document (30) Docket Text: REDACTED VERSION of [314] Statement, by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Oct 9, 2020 | 336 | Redacted Document (21) Docket Text: REDACTED VERSION of [315] Answering Brief in Opposition, by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Oct 9, 2020 | 337 | Redacted Document (30) Docket Text: REDACTED VERSION of [319] Statement, by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Oct 9, 2020 | 338 | Redacted Document (17) Docket Text: REDACTED VERSION of [322] Answering Brief in Opposition, by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Oct 9, 2020 | 339 | Redacted Document (19) Docket Text: REDACTED VERSION of [324] Answering Brief in Opposition, by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Oct 9, 2020 | 340 | Redacted Document (4) Docket Text: REDACTED VERSION of [327] Declaration,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-U)(Farnan, Brian) |
| Oct 9, 2020 | 340 | Exhibits A-U (105) |
| Oct 9, 2020 | 341 | Redacted Document (21) Docket Text: REDACTED VERSION of [320] Answering Brief in Opposition, by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Oct 9, 2020 | 342 | Redacted Document (22) Docket Text: REDACTED VERSION of [313] Answering Brief in Opposition, by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Oct 9, 2020 | 343 | Redacted Document (18) Docket Text: REDACTED VERSION of [316] Statement, by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Oct 9, 2020 | 344 | Redacted Document (14) Docket Text: REDACTED VERSION of [317] Answering Brief in Opposition, by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Oct 9, 2020 | 345 | Redacted Document (12) Docket Text: REDACTED VERSION of [318] Statement, by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Oct 9, 2020 | 346 | Redacted Document (9) Docket Text: REDACTED VERSION of [321] Answering Brief in Opposition, by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Oct 9, 2020 | 347 | Redacted Document (9) Docket Text: REDACTED VERSION of [323] Statement, by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Oct 9, 2020 | 348 | Redacted Document (8) Docket Text: REDACTED VERSION of [325] Answering Brief in Opposition, by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Oct 9, 2020 | 349 | Redacted Document (25) Docket Text: REDACTED VERSION of [326] Answering Brief in Opposition, by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Oct 9, 2020 | 350 | Redacted Document (30) Docket Text: REDACTED VERSION of [328] Declaration, by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Oct 9, 2020 | 351 | Redacted Document (30) Docket Text: REDACTED VERSION of [329] Exhibit to a Document by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Oct 9, 2020 | 352 | Redacted Document (30) Docket Text: REDACTED VERSION of [330] Exhibit to a Document by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Oct 9, 2020 | 353 | Redacted Document (30) Docket Text: REDACTED VERSION of [331] Exhibit to a Document by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Oct 9, 2020 | 340 | Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [327] Declaration,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-U)(Farnan, Brian) |
| Oct 9, 2020 | 340 | Redacted Document (Exhibits A-U) (30) Docket Text: REDACTED VERSION of [327] Declaration,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-U)(Farnan, Brian) |
| Sep 21, 2020 | 309 | Redacted Document (13) Docket Text: REDACTED VERSION of [287] Response to Objections by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-N)(Mowery, Katharine) |
| Sep 21, 2020 | 309 | Exhibit A-N (68) |
| Sep 21, 2020 | 309 | Redacted Document (Main Document) (13) Docket Text: REDACTED VERSION of [287] Response to Objections by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-N)(Mowery, Katharine) |
| Sep 21, 2020 | 309 | Redacted Document (Exhibit A-N) (30) Docket Text: REDACTED VERSION of [287] Response to Objections by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-N)(Mowery, Katharine) |
| Sep 18, 2020 | 288 | Redacted Document (16) Docket Text: REDACTED VERSION of [275] Opening Brief in Support, by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Mowery, Katharine) |
| Sep 18, 2020 | 288 | Certificate of Compliance (1) |
| Sep 18, 2020 | 289 | Redacted Document (12) Docket Text: REDACTED VERSION of [276] Statement, by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Mowery, Katharine) |
| Sep 18, 2020 | 289 | Certificate of Compliance (1) |
| Sep 18, 2020 | 290 | Redacted Document (8) Docket Text: REDACTED VERSION of [277] MOTION No. 5: L'Oreal USA, Inc.'s Motion to Exclude Certain Opinions of Ms. Julie Davis by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Certificate of Compliance, # (3) 7.1.1 Statement)(Mowery, Katharine) |
| Sep 18, 2020 | 290 | Text of Proposed Order (1) |
| Sep 18, 2020 | 290 | Certificate of Compliance (1) |
| Sep 18, 2020 | 290 | 7.1.1 Statement (1) |
| Sep 18, 2020 | 291 | Redacted Document (27) Docket Text: REDACTED VERSION of [257] Opening Brief in Support, by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Sep 18, 2020 | 292 | Redacted Document (3) Docket Text: REDACTED VERSION of [258] Declaration, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-12)(Farnan, Brian) |
| Sep 18, 2020 | 292 | Exhibits 1-12 (206) |
| Sep 18, 2020 | 293 | Redacted Document (26) Docket Text: REDACTED VERSION of [260] Opening Brief in Support, by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Sep 18, 2020 | 294 | Redacted Document (30) Docket Text: REDACTED VERSION of [261] Statement, by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Sep 18, 2020 | 295 | Redacted Document (13) Docket Text: REDACTED VERSION of [263] Opening Brief in Support, by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Sep 18, 2020 | 296 | Redacted Document (30) Docket Text: REDACTED VERSION of [264] Statement, by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Sep 18, 2020 | 297 | Redacted Document (9) Docket Text: REDACTED VERSION of [266] Opening Brief in Support, by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Sep 18, 2020 | 298 | Redacted Document (19) Docket Text: REDACTED VERSION of [267] Statement, by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Sep 18, 2020 | 299 | Redacted Document (20) Docket Text: REDACTED VERSION of [269] Opening Brief in Support, by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Sep 18, 2020 | 300 | Redacted Document (4) Docket Text: REDACTED VERSION of [270] Declaration,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-21)(Farnan, Brian) |
| Sep 18, 2020 | 300 | Exhibits 1-21 (181) |
| Sep 18, 2020 | 301 | Redacted Document (8) Docket Text: REDACTED VERSION of [272] Opening Brief in Support, by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Sep 18, 2020 | 302 | Redacted Document (2) Docket Text: REDACTED VERSION of [273] Declaration by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-3)(Farnan, Brian) |
| Sep 18, 2020 | 302 | Exhibits 1-3 (22) |
| Sep 18, 2020 | 303 | Redacted Document (18) Docket Text: REDACTED VERSION of [279] Opening Brief in Support, by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Mowery, Katharine) |
| Sep 18, 2020 | 303 | Certificate of Compliance (1) |
| Sep 18, 2020 | 304 | Redacted Document (11) Docket Text: REDACTED VERSION of [280] Statement by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Mowery, Katharine) |
| Sep 18, 2020 | 304 | Certificate of Compliance (1) |
| Sep 18, 2020 | 305 | Redacted Document (24) Docket Text: REDACTED VERSION of [282] Opening Brief in Support, by L'Oreal USA, Inc.. (Mowery, Katharine) |
| Sep 18, 2020 | 306 | Redacted Document (8) Docket Text: REDACTED VERSION of [286] Declaration,,, by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit 1-4 Volume 1, # (2) Exhibit 5-19 Volume 2, # (3) Notice of Motion 20-38 Volume 3)(Mowery, Katharine) |
| Sep 18, 2020 | 306 | Exhibit 1-4 Volume 1 (23) |
| Sep 18, 2020 | 306 | Exhibit 5-19 Volume 2 (295) |
| Sep 18, 2020 | 306 | Notice of Motion 20-38 Volume 3 (323) |
| Sep 18, 2020 | 307 | Redacted Document (24) Docket Text: REDACTED VERSION of [284] Opening Brief in Support, by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Mowery, Katharine) |
| Sep 18, 2020 | 307 | Certificate of Compliance (1) |
| Sep 18, 2020 | 308 | Redacted Document (14) Docket Text: REDACTED VERSION of [285] Statement by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Mowery, Katharine) |
| Sep 18, 2020 | 308 | Certificate of Compliance (1) |
| Sep 18, 2020 | 288 | Redacted Document (Main Document) (16) Docket Text: REDACTED VERSION of [275] Opening Brief in Support, by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Mowery, Katharine) |
| Sep 18, 2020 | 288 | Redacted Document (Certificate of Compliance) (1) Docket Text: REDACTED VERSION of [275] Opening Brief in Support, by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Mowery, Katharine) |
| Sep 18, 2020 | 289 | Redacted Document (Main Document) (12) Docket Text: REDACTED VERSION of [276] Statement, by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Mowery, Katharine) |
| Sep 18, 2020 | 289 | Redacted Document (Certificate of Compliance) (1) Docket Text: REDACTED VERSION of [276] Statement, by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Mowery, Katharine) |
| Sep 18, 2020 | 290 | Redacted Document (Main Document) (8) Docket Text: REDACTED VERSION of [277] MOTION No. 5: L'Oreal USA, Inc.'s Motion to Exclude Certain Opinions of Ms. Julie Davis by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Certificate of Compliance, # (3) 7.1.1 Statement)(Mowery, Katharine) |
| Sep 18, 2020 | 290 | Redacted Document (Text of Proposed Order) (1) Docket Text: REDACTED VERSION of [277] MOTION No. 5: L'Oreal USA, Inc.'s Motion to Exclude Certain Opinions of Ms. Julie Davis by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Certificate of Compliance, # (3) 7.1.1 Statement)(Mowery, Katharine) |
| Sep 18, 2020 | 290 | Redacted Document (Certificate of Compliance) (1) Docket Text: REDACTED VERSION of [277] MOTION No. 5: L'Oreal USA, Inc.'s Motion to Exclude Certain Opinions of Ms. Julie Davis by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Certificate of Compliance, # (3) 7.1.1 Statement)(Mowery, Katharine) |
| Sep 18, 2020 | 290 | Redacted Document (7.1.1 Statement) (1) Docket Text: REDACTED VERSION of [277] MOTION No. 5: L'Oreal USA, Inc.'s Motion to Exclude Certain Opinions of Ms. Julie Davis by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Certificate of Compliance, # (3) 7.1.1 Statement)(Mowery, Katharine) |
| Sep 18, 2020 | 292 | Redacted Document (Main Document) (3) Docket Text: REDACTED VERSION of [258] Declaration, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-12)(Farnan, Brian) |
| Sep 18, 2020 | 292 | Redacted Document (Exhibits 1-12) (30) Docket Text: REDACTED VERSION of [258] Declaration, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-12)(Farnan, Brian) |
| Sep 18, 2020 | 300 | Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [270] Declaration,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-21)(Farnan, Brian) |
| Sep 18, 2020 | 300 | Redacted Document (Exhibits 1-21) (30) Docket Text: REDACTED VERSION of [270] Declaration,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-21)(Farnan, Brian) |
| Sep 18, 2020 | 302 | Redacted Document (Main Document) (2) Docket Text: REDACTED VERSION of [273] Declaration by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-3)(Farnan, Brian) |
| Sep 18, 2020 | 302 | Redacted Document (Exhibits 1-3) (22) Docket Text: REDACTED VERSION of [273] Declaration by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-3)(Farnan, Brian) |
| Sep 18, 2020 | 303 | Redacted Document (Main Document) (18) Docket Text: REDACTED VERSION of [279] Opening Brief in Support, by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Mowery, Katharine) |
| Sep 18, 2020 | 303 | Redacted Document (Certificate of Compliance) (1) Docket Text: REDACTED VERSION of [279] Opening Brief in Support, by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Mowery, Katharine) |
| Sep 18, 2020 | 304 | Redacted Document (Main Document) (11) Docket Text: REDACTED VERSION of [280] Statement by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Mowery, Katharine) |
| Sep 18, 2020 | 304 | Redacted Document (Certificate of Compliance) (1) Docket Text: REDACTED VERSION of [280] Statement by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Mowery, Katharine) |
| Sep 18, 2020 | 306 | Redacted Document (Main Document) (8) Docket Text: REDACTED VERSION of [286] Declaration,,, by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit 1-4 Volume 1, # (2) Exhibit 5-19 Volume 2, # (3) Notice of Motion 20-38 Volume 3)(Mowery, Katharine) |
| Sep 18, 2020 | 306 | Redacted Document (Exhibit 1-4 Volume 1) (23) Docket Text: REDACTED VERSION of [286] Declaration,,, by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit 1-4 Volume 1, # (2) Exhibit 5-19 Volume 2, # (3) Notice of Motion 20-38 Volume 3)(Mowery, Katharine) |
| Sep 18, 2020 | 306 | Redacted Document (Exhibit 5-19 Volume 2) (30) Docket Text: REDACTED VERSION of [286] Declaration,,, by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit 1-4 Volume 1, # (2) Exhibit 5-19 Volume 2, # (3) Notice of Motion 20-38 Volume 3)(Mowery, Katharine) |
| Sep 18, 2020 | 306 | Redacted Document (Notice of Motion 20-38 Volume 3) (30) Docket Text: REDACTED VERSION of [286] Declaration,,, by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit 1-4 Volume 1, # (2) Exhibit 5-19 Volume 2, # (3) Notice of Motion 20-38 Volume 3)(Mowery, Katharine) |
| Sep 18, 2020 | 307 | Redacted Document (Main Document) (24) Docket Text: REDACTED VERSION of [284] Opening Brief in Support, by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Mowery, Katharine) |
| Sep 18, 2020 | 307 | Redacted Document (Certificate of Compliance) (1) Docket Text: REDACTED VERSION of [284] Opening Brief in Support, by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Mowery, Katharine) |
| Sep 18, 2020 | 308 | Redacted Document (Main Document) (14) Docket Text: REDACTED VERSION of [285] Statement by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Mowery, Katharine) |
| Sep 18, 2020 | 308 | Redacted Document (Certificate of Compliance) (1) Docket Text: REDACTED VERSION of [285] Statement by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance)(Mowery, Katharine) |
| Sep 11, 2020 | N/A | Motions No Longer Referred (0) Docket Text: Motions No Longer Referred: [265] MOTION for Partial Summary Judgment on Enablement, [274] MOTION for Summary Judgment of Indefiniteness of the Dermal Cell Adenosine Concentration Claim Limitation, [268] MOTION to Preclude Untimely and Irrelevant Opinions Regarding Damages, [262] MOTION for Partial Summary Judgment of Non-Obviousness, [259] MOTION for Partial Summary Judgment of No Anticipation, [278] MOTION for Summary Judgment of Indefiniteness of the Skin Enhancement Claim Limitation, [256] MOTION to Strike Untimely Invalidity Theories and References, [277] MOTION No. 5: L'Oreal USA, Inc.'s Motion to Exclude Certain Opinions of Ms. Julie Davis , [271] MOTION to Preclude Irrelevant Opinions About Inventor Declarations to the PTO, [283] MOTION for Summary Judgment of Anticipation, [281] MOTION No. 4: L'Oreal USA, Inc.'s Motion to Exclude Expert Opinions Related to Dr. Kisak's Testing. The automatic motion referrals generated by the system have been removed. (nmf) |
| Sep 11, 2020 | 255 | Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by Katharine Lester Mowery (Mowery, Katharine) |
| Sep 11, 2020 | 256 | Motion to Strike (3) Docket Text: MOTION to Strike Untimely Invalidity Theories and References - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Sep 11, 2020 | 256 | Text of Proposed Order (1) |
| Sep 11, 2020 | 259 | Motion for Partial Summary Judgment (3) Docket Text: MOTION for Partial Summary Judgment of No Anticipation - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Sep 11, 2020 | 259 | Text of Proposed Order (1) |
| Sep 11, 2020 | 262 | Motion for Partial Summary Judgment (3) Docket Text: MOTION for Partial Summary Judgment of Non-Obviousness - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Sep 11, 2020 | 262 | Text of Proposed Order (1) |
| Sep 11, 2020 | 265 | Motion for Partial Summary Judgment (3) Docket Text: MOTION for Partial Summary Judgment on Enablement - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Sep 11, 2020 | 265 | Text of Proposed Order (1) |
| Sep 11, 2020 | 268 | Motion to Preclude (3) Docket Text: MOTION to Preclude Untimely and Irrelevant Opinions Regarding Damages - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Sep 11, 2020 | 268 | Text of Proposed Order (1) |
| Sep 11, 2020 | 271 | Motion to Preclude (3) Docket Text: MOTION to Preclude Irrelevant Opinions About Inventor Declarations to the PTO - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Sep 11, 2020 | 271 | Text of Proposed Order (1) |
| Sep 11, 2020 | 274 | Motion for Summary Judgment (2) Docket Text: MOTION for Summary Judgment of Indefiniteness of the Dermal Cell Adenosine Concentration Claim Limitation - filed by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Mowery, Katharine) |
| Sep 11, 2020 | 274 | Text of Proposed Order (1) |
| Sep 11, 2020 | 278 | Motion for Summary Judgment (2) Docket Text: MOTION for Summary Judgment of Indefiniteness of the Skin Enhancement Claim Limitation - filed by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Mowery, Katharine) |
| Sep 11, 2020 | 278 | Text of Proposed Order (1) |
| Sep 11, 2020 | 281 | Motion for Miscellaneous Relief (2) Docket Text: MOTION No. 4: L'Oreal USA, Inc.'s Motion to Exclude Expert Opinions Related to Dr. Kisak's Testing - filed by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Cottrell, Frederick) |
| Sep 11, 2020 | 281 | Text of Proposed Order (1) |
| Sep 11, 2020 | 283 | Motion for Summary Judgment (2) Docket Text: MOTION for Summary Judgment of Anticipation - filed by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Mowery, Katharine) |
| Sep 11, 2020 | 283 | Text of Proposed Order (1) |
| Sep 11, 2020 | N/A | Motions No Longer Referred (0) Docket Text: Motions No Longer Referred: [265] MOTION for Partial Summary Judgment on Enablement, [274] MOTION for Summary Judgment of Indefiniteness of the Dermal Cell Adenosine Concentration Claim Limitation, [268] MOTION to Preclude Untimely and Irrelevant Opinions Regarding Damages, [262] MOTION for Partial Summary Judgment of Non-Obviousness, [259] MOTION for Partial Summary Judgment of No Anticipation, [278] MOTION for Summary Judgment of Indefiniteness of the Skin Enhancement Claim Limitation, [256] MOTION to Strike Untimely Invalidity Theories and References, [277] MOTION No. 5: L'Oreal USA, Inc.'s Motion to Exclude Certain Opinions of Ms. Julie Davis , [271] MOTION to Preclude Irrelevant Opinions About Inventor Declarations to the PTO, [283] MOTION for Summary Judgment of Anticipation, [281] MOTION No. 4: L'Oreal USA, Inc.'s Motion to Exclude Expert Opinions Related to Dr. Kisak's Testing. The automatic motion referrals generated by the system have been removed. (nmf) |
| Sep 11, 2020 | 256 | Motion to Strike (Main Document) (3) Docket Text: MOTION to Strike Untimely Invalidity Theories and References - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Sep 11, 2020 | 256 | Motion to Strike (Text of Proposed Order) (1) Docket Text: MOTION to Strike Untimely Invalidity Theories and References - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Sep 11, 2020 | 259 | Motion for Partial Summary Judgment (Main Document) (3) Docket Text: MOTION for Partial Summary Judgment of No Anticipation - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Sep 11, 2020 | 259 | Motion for Partial Summary Judgment (Text of Proposed Order) (1) Docket Text: MOTION for Partial Summary Judgment of No Anticipation - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Sep 11, 2020 | 262 | Motion for Partial Summary Judgment (Main Document) (3) Docket Text: MOTION for Partial Summary Judgment of Non-Obviousness - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Sep 11, 2020 | 262 | Motion for Partial Summary Judgment (Text of Proposed Order) (1) Docket Text: MOTION for Partial Summary Judgment of Non-Obviousness - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Sep 11, 2020 | 265 | Motion for Partial Summary Judgment (Main Document) (3) Docket Text: MOTION for Partial Summary Judgment on Enablement - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Sep 11, 2020 | 265 | Motion for Partial Summary Judgment (Text of Proposed Order) (1) Docket Text: MOTION for Partial Summary Judgment on Enablement - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Sep 11, 2020 | 268 | Motion to Preclude (Main Document) (3) Docket Text: MOTION to Preclude Untimely and Irrelevant Opinions Regarding Damages - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Sep 11, 2020 | 268 | Motion to Preclude (Text of Proposed Order) (1) Docket Text: MOTION to Preclude Untimely and Irrelevant Opinions Regarding Damages - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Sep 11, 2020 | 271 | Motion to Preclude (Main Document) (3) Docket Text: MOTION to Preclude Irrelevant Opinions About Inventor Declarations to the PTO - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Sep 11, 2020 | 271 | Motion to Preclude (Text of Proposed Order) (1) Docket Text: MOTION to Preclude Irrelevant Opinions About Inventor Declarations to the PTO - filed by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Sep 11, 2020 | 274 | Motion for Summary Judgment (Main Document) (2) Docket Text: MOTION for Summary Judgment of Indefiniteness of the Dermal Cell Adenosine Concentration Claim Limitation - filed by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Mowery, Katharine) |
| Sep 11, 2020 | 274 | Motion for Summary Judgment (Text of Proposed Order) (1) Docket Text: MOTION for Summary Judgment of Indefiniteness of the Dermal Cell Adenosine Concentration Claim Limitation - filed by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Mowery, Katharine) |
| Sep 11, 2020 | 278 | Motion for Summary Judgment (Main Document) (2) Docket Text: MOTION for Summary Judgment of Indefiniteness of the Skin Enhancement Claim Limitation - filed by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Mowery, Katharine) |
| Sep 11, 2020 | 278 | Motion for Summary Judgment (Text of Proposed Order) (1) Docket Text: MOTION for Summary Judgment of Indefiniteness of the Skin Enhancement Claim Limitation - filed by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Mowery, Katharine) |
| Sep 11, 2020 | 281 | Motion for Miscellaneous Relief (Main Document) (2) Docket Text: MOTION No. 4: L'Oreal USA, Inc.'s Motion to Exclude Expert Opinions Related to Dr. Kisak's Testing - filed by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Cottrell, Frederick) |
| Sep 11, 2020 | 281 | Motion for Miscellaneous Relief (Text of Proposed Order) (1) Docket Text: MOTION No. 4: L'Oreal USA, Inc.'s Motion to Exclude Expert Opinions Related to Dr. Kisak's Testing - filed by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Cottrell, Frederick) |
| Sep 11, 2020 | 283 | Motion for Summary Judgment (Main Document) (2) Docket Text: MOTION for Summary Judgment of Anticipation - filed by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Mowery, Katharine) |
| Sep 11, 2020 | 283 | Motion for Summary Judgment (Text of Proposed Order) (1) Docket Text: MOTION for Summary Judgment of Anticipation - filed by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Mowery, Katharine) |
| Sep 8, 2020 | 254 | Redacted Document (15) Docket Text: REDACTED VERSION of [253] Objections, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-N, # (2) Text of Proposed Order, # (3) Certification)(Farnan, Brian) |
| Sep 8, 2020 | 254 | Exhibits A-N (89) |
| Sep 8, 2020 | 254 | Text of Proposed Order (2) |
| Sep 8, 2020 | 254 | Certification (3) |
| Sep 8, 2020 | 254 | Redacted Document (Main Document) (15) Docket Text: REDACTED VERSION of [253] Objections, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-N, # (2) Text of Proposed Order, # (3) Certification)(Farnan, Brian) |
| Sep 8, 2020 | 254 | Redacted Document (Exhibits A-N) (30) Docket Text: REDACTED VERSION of [253] Objections, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-N, # (2) Text of Proposed Order, # (3) Certification)(Farnan, Brian) |
| Sep 8, 2020 | 254 | Redacted Document (Text of Proposed Order) (2) Docket Text: REDACTED VERSION of [253] Objections, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-N, # (2) Text of Proposed Order, # (3) Certification)(Farnan, Brian) |
| Sep 8, 2020 | 254 | Redacted Document (Certification) (3) Docket Text: REDACTED VERSION of [253] Objections, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-N, # (2) Text of Proposed Order, # (3) Certification)(Farnan, Brian) |
| Aug 19, 2020 | 251 | Redacted Document (6) Docket Text: REDACTED VERSION of [246] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A - O)(Cottrell, Frederick) |
| Aug 19, 2020 | 251 | Exhibit A - O (141) |
| Aug 19, 2020 | 252 | Redacted Document (5) Docket Text: REDACTED VERSION of [247] Declaration by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A - B)(Cottrell, Frederick) |
| Aug 19, 2020 | 252 | Exhibit A - B (1) |
| Aug 19, 2020 | 251 | Redacted Document (Main Document) (6) Docket Text: REDACTED VERSION of [246] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A - O)(Cottrell, Frederick) |
| Aug 19, 2020 | 251 | Redacted Document (Exhibit A - O) (30) Docket Text: REDACTED VERSION of [246] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A - O)(Cottrell, Frederick) |
| Aug 19, 2020 | 252 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [247] Declaration by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A - B)(Cottrell, Frederick) |
| Aug 19, 2020 | 252 | Redacted Document (Exhibit A - B) (1) Docket Text: REDACTED VERSION of [247] Declaration by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A - B)(Cottrell, Frederick) |
| Aug 18, 2020 | 250 | Redacted Document (4) Docket Text: REDACTED VERSION of [242] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-R)(Farnan, Brian) |
| Aug 18, 2020 | 250 | Exhibits A-R (122) |
| Aug 18, 2020 | 250 | Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [242] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-R)(Farnan, Brian) |
| Aug 18, 2020 | 250 | Redacted Document (Exhibits A-R) (30) Docket Text: REDACTED VERSION of [242] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-R)(Farnan, Brian) |
| Aug 17, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [238] MOTION to Resolve Discovery Dispute. The transcript of the discovery dispute teleconference held on 8/17/2020 shall serve as the order of the court. Signed by Judge Sherry R. Fallon on 8/17/2020. (Polito, Rebecca) |
| Aug 17, 2020 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Sherry R. Fallon - Discovery Conference held on 8/17/2020. (Court Reporter Val Gunning.) (Polito, Rebecca) |
| Aug 17, 2020 | 248 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Reply Expert Report and Disclosure of Julie L. Davis filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Aug 17, 2020 | 249 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Julie L. Davis on August 26, 2020 filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Aug 11, 2020 | 243 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Dr. Gerald B. Kasting on 8/21/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Michael) |
| Aug 11, 2020 | 244 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Dr. Majella Lane on 8/14/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Michael) |
| Aug 11, 2020 | 245 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Paul Meyer on 8/28/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Michael) |
| Aug 10, 2020 | 240 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Professor Gerald B. Kasting, Ph.D. and Reply Expert Report of Majella Lane, Ph.D. filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Aug 10, 2020 | 241 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Reply Expert Report of Bozena Michniak-Kohn, Ph.D. Regarding Infringement and (ii) Reply Report of Edward Kisak filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Aug 3, 2020 | 239 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Expert Rebuttal Report of Paul K. Meyer filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Jul 28, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED- re [238] MOTION to Resolve Discovery Dispute. A Discovery Dispute Hearing is set for 8/17/2020 at 11:00 AM before Judge Sherry R. Fallon. The Discovery Dispute Hearing will be conducted via videoconference/teleconference; THEREFORE, IT IS HEREBY ORDERED that: counsel shall provide videoconference/teleconference details to Judge Fallon's courtroom deputy by no later than noon on 8/13/2020. In preparation for this hearing the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Order regarding discovery matters available at www.ded.uscourts.gov/judge/magistrate-judge-sherry-r-fallon. Set Deadlines: (Moving Submission due by no later than 11:00 AM on 8/11/2020, Responsive submission due by no later than 11:00 AM on 8/12/2020.) Signed by Judge Sherry R. Fallon on 7/28/2020. (lih) |
| Jul 28, 2020 | 238 | Motion for Miscellaneous Relief (2) Docket Text: MOTION to Resolve Discovery Dispute - filed by Carmel Laboratories, LLC, University of Massachusetts. Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Jul 22, 2020 | 236 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Rebuttal Expert Report of Bozena Michniak-Kohn, Ph.D. Regarding Validity filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jul 22, 2020 | 237 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Rebuttal Expert Report of Professor Gerald B. Kasting, Ph.D. filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Jul 10, 2020 | 235 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant L'Oreal USA, Inc.'s Second Amended Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Jul 6, 2020 | 234 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Expert Report and Disclosure of Julie L. Davis filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 30, 2020 | N/A | Remark (0) Docket Text: D.I. [125] and D.I. [144] have been unsealed per D.I. [228]. (nmf) |
| Jun 30, 2020 | 222 | Redacted Document (5) Docket Text: REDACTED VERSION of [88] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-M, # (2) Text of Proposed Order)(Farnan, Brian) |
| Jun 30, 2020 | 222 | Exhibits A-M (95) |
| Jun 30, 2020 | 222 | Text of Proposed Order (1) |
| Jun 30, 2020 | 223 | Redacted Document (4) Docket Text: REDACTED VERSION of [90] Letter by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits N-P)(Farnan, Brian) |
| Jun 30, 2020 | 223 | Exhibits N-P (32) |
| Jun 30, 2020 | 224 | Redacted Document (5) Docket Text: REDACTED VERSION of [103] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-L, # (2) Text of Proposed Order)(Farnan, Brian) |
| Jun 30, 2020 | 224 | Exhibits A-L (77) |
| Jun 30, 2020 | 224 | Text of Proposed Order (2) |
| Jun 30, 2020 | 225 | Redacted Document (4) Docket Text: REDACTED VERSION of [120] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-24, # (2) Text of Proposed Order)(Farnan, Brian) |
| Jun 30, 2020 | 225 | Exhibits 1-24 (184) |
| Jun 30, 2020 | 225 | Text of Proposed Order (2) |
| Jun 30, 2020 | 226 | Redacted Document (4) Docket Text: REDACTED VERSION of [156] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-T)(Farnan, Brian) |
| Jun 30, 2020 | 226 | Exhibits A-T (194) |
| Jun 30, 2020 | 227 | Redacted Document (5) Docket Text: REDACTED VERSION of [159] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-U)(Farnan, Brian) |
| Jun 30, 2020 | 227 | Exhibits A-U (148) |
| Jun 30, 2020 | 228 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Katharine L. Mowery regarding Unsealing and Unredacting Docket Entries - re Oral Order,. (Mowery, Katharine) |
| Jun 30, 2020 | 229 | Redacted Document (5) Docket Text: REDACTED VERSION of [89] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-D)(Mowery, Katharine) |
| Jun 30, 2020 | 229 | Exhibit A-D (45) |
| Jun 30, 2020 | 230 | Redacted Document (3) Docket Text: REDACTED VERSION of [126] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A)(Mowery, Katharine) |
| Jun 30, 2020 | 230 | Exhibit A (1) |
| Jun 30, 2020 | 231 | Redacted Document (5) Docket Text: REDACTED VERSION of [160] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit B-P)(Mowery, Katharine) |
| Jun 30, 2020 | 231 | Text of Proposed Order (3) |
| Jun 30, 2020 | 231 | Exhibit B-P (121) |
| Jun 30, 2020 | 232 | Redacted Document (5) Docket Text: REDACTED VERSION of [164] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-G)(Mowery, Katharine) |
| Jun 30, 2020 | 232 | Exhibit A-G (89) |
| Jun 30, 2020 | 233 | Redacted Document (4) Docket Text: REDACTED VERSION of [155] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-D)(Mowery, Katharine) |
| Jun 30, 2020 | 233 | Exhibit A-D (16) |
| Jun 30, 2020 | 222 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [88] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-M, # (2) Text of Proposed Order)(Farnan, Brian) |
| Jun 30, 2020 | 222 | Redacted Document (Exhibits A-M) (30) Docket Text: REDACTED VERSION of [88] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-M, # (2) Text of Proposed Order)(Farnan, Brian) |
| Jun 30, 2020 | 222 | Redacted Document (Text of Proposed Order) (1) Docket Text: REDACTED VERSION of [88] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-M, # (2) Text of Proposed Order)(Farnan, Brian) |
| Jun 30, 2020 | 223 | Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [90] Letter by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits N-P)(Farnan, Brian) |
| Jun 30, 2020 | 223 | Redacted Document (Exhibits N-P) (30) Docket Text: REDACTED VERSION of [90] Letter by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits N-P)(Farnan, Brian) |
| Jun 30, 2020 | 224 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [103] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-L, # (2) Text of Proposed Order)(Farnan, Brian) |
| Jun 30, 2020 | 224 | Redacted Document (Exhibits A-L) (30) Docket Text: REDACTED VERSION of [103] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-L, # (2) Text of Proposed Order)(Farnan, Brian) |
| Jun 30, 2020 | 224 | Redacted Document (Text of Proposed Order) (2) Docket Text: REDACTED VERSION of [103] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-L, # (2) Text of Proposed Order)(Farnan, Brian) |
| Jun 30, 2020 | 225 | Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [120] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-24, # (2) Text of Proposed Order)(Farnan, Brian) |
| Jun 30, 2020 | 225 | Redacted Document (Exhibits 1-24) (30) Docket Text: REDACTED VERSION of [120] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-24, # (2) Text of Proposed Order)(Farnan, Brian) |
| Jun 30, 2020 | 225 | Redacted Document (Text of Proposed Order) (2) Docket Text: REDACTED VERSION of [120] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-24, # (2) Text of Proposed Order)(Farnan, Brian) |
| Jun 30, 2020 | 226 | Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [156] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-T)(Farnan, Brian) |
| Jun 30, 2020 | 226 | Redacted Document (Exhibits A-T) (30) Docket Text: REDACTED VERSION of [156] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-T)(Farnan, Brian) |
| Jun 30, 2020 | 227 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [159] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-U)(Farnan, Brian) |
| Jun 30, 2020 | 227 | Redacted Document (Exhibits A-U) (30) Docket Text: REDACTED VERSION of [159] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-U)(Farnan, Brian) |
| Jun 30, 2020 | 229 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [89] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-D)(Mowery, Katharine) |
| Jun 30, 2020 | 229 | Redacted Document (Exhibit A-D) (30) Docket Text: REDACTED VERSION of [89] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-D)(Mowery, Katharine) |
| Jun 30, 2020 | 230 | Redacted Document (Main Document) (3) Docket Text: REDACTED VERSION of [126] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A)(Mowery, Katharine) |
| Jun 30, 2020 | 230 | Redacted Document (Exhibit A) (1) Docket Text: REDACTED VERSION of [126] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A)(Mowery, Katharine) |
| Jun 30, 2020 | 231 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [160] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit B-P)(Mowery, Katharine) |
| Jun 30, 2020 | 231 | Redacted Document (Text of Proposed Order) (3) Docket Text: REDACTED VERSION of [160] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit B-P)(Mowery, Katharine) |
| Jun 30, 2020 | 231 | Redacted Document (Exhibit B-P) (30) Docket Text: REDACTED VERSION of [160] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit B-P)(Mowery, Katharine) |
| Jun 30, 2020 | 232 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [164] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-G)(Mowery, Katharine) |
| Jun 30, 2020 | 232 | Redacted Document (Exhibit A-G) (30) Docket Text: REDACTED VERSION of [164] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-G)(Mowery, Katharine) |
| Jun 30, 2020 | 233 | Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [155] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-D)(Mowery, Katharine) |
| Jun 30, 2020 | 233 | Redacted Document (Exhibit A-D) (16) Docket Text: REDACTED VERSION of [155] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-D)(Mowery, Katharine) |
| Jun 29, 2020 | 220 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Expert Report of Majella Lane, Ph.D. and Expert Report of Professor Gerald B. Kasting, Ph.D. filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Jun 29, 2020 | 221 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Expert Report of Bozena Michniak-Kohn, Ph.D. and (ii) Expert Report of Edward Kisak, Ph.D. filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 26, 2020 | 219 | Redacted Document (5) Docket Text: REDACTED VERSION of [214] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-F)(Mowery, Katharine) |
| Jun 26, 2020 | 219 | Exhibit A-F (223) |
| Jun 26, 2020 | 219 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [214] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-F)(Mowery, Katharine) |
| Jun 26, 2020 | 219 | Redacted Document (Exhibit A-F) (30) Docket Text: REDACTED VERSION of [214] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-F)(Mowery, Katharine) |
| Jun 25, 2020 | 217 | Redacted Document (5) Docket Text: REDACTED VERSION of [211] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-H)(Farnan, Brian) |
| Jun 25, 2020 | 217 | Exhibits A-H (35) |
| Jun 25, 2020 | 218 | Redacted Document (5) Docket Text: REDACTED VERSION of [210] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-K)(Mowery, Katharine) |
| Jun 25, 2020 | 218 | Exhibit A-K (72) |
| Jun 25, 2020 | 217 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [211] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-H)(Farnan, Brian) |
| Jun 25, 2020 | 217 | Redacted Document (Exhibits A-H) (30) Docket Text: REDACTED VERSION of [211] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-H)(Farnan, Brian) |
| Jun 25, 2020 | 218 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [210] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-K)(Mowery, Katharine) |
| Jun 25, 2020 | 218 | Redacted Document (Exhibit A-K) (30) Docket Text: REDACTED VERSION of [210] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-K)(Mowery, Katharine) |
| Jun 23, 2020 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Sherry R. Fallon - Discovery Dispute Telephone Conference held on 6/23/2020. (Court Reporter V. Gunning.) (lih) |
| Jun 23, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED-re [212] MOTION for Pro Hac Vice Appearance of Attorney Matthew B. Lowrie. Signed by Judge Sherry R. Fallon on 6/23/2020. (lih) |
| Jun 23, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER- IT IS HEREBY ORDERED that the transcript of the 6/23/2020 discovery dispute hearing shall serve as the order of the court. Ordered by Judge Sherry R. Fallon on 6/23/2020. (lih) |
| Jun 19, 2020 | 213 | Letter (1) Docket Text: Letter to The Honorable Sherry R. Fallon from Frederick L. Cottrell, III regarding Removal of Discovery Dispute from Agenda for June 23 Teleconference. (Cottrell, Frederick) |
| Jun 19, 2020 | 215 | Letter (1) Docket Text: Letter to The Honorable Sherry R. Fallon from Brian E. Farnan regarding June 18, 2020 Letter - re [211] Letter,. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Farnan, Brian) |
| Jun 19, 2020 | 215 | Exhibit 1 (16) |
| Jun 19, 2020 | 215 | Exhibit 2 (6) |
| Jun 19, 2020 | 216 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Objections to Notice of Deposition Pursuant to Rule 30(b)(6) filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Jun 19, 2020 | 215 | Letter (Main Document) (1) Docket Text: Letter to The Honorable Sherry R. Fallon from Brian E. Farnan regarding June 18, 2020 Letter - re [211] Letter,. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Farnan, Brian) |
| Jun 19, 2020 | 215 | Letter (Exhibit 1) (16) Docket Text: Letter to The Honorable Sherry R. Fallon from Brian E. Farnan regarding June 18, 2020 Letter - re [211] Letter,. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Farnan, Brian) |
| Jun 19, 2020 | 215 | Letter (Exhibit 2) (6) Docket Text: Letter to The Honorable Sherry R. Fallon from Brian E. Farnan regarding June 18, 2020 Letter - re [211] Letter,. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Farnan, Brian) |
| Jun 18, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. [211] has been replaced with a revised version of the document per the request of counsel. (lih) |
| Jun 18, 2020 | 212 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Matthew B. Lowrie - filed by Carmel Laboratories, LLC. Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Jun 16, 2020 | 209 | Redacted Document (14) Docket Text: REDACTED VERSION of [177] Response to Objections by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Jun 15, 2020 | N/A | Oral Order (0) Docket Text: SO ORDERED- re [207] MOTION to Resolve Discovery Dispute. In preparation for this hearing the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Order regarding discovery matters available at www.ded.uscourts.gov/judge/magistrate-judge-sherry-r-fallon. Set Deadlines: (Moving Submissions due by no later than 11:00 AM on 6/18/2020, Responsive submissions due by no later than 11:00 AM on 6/19/2020.) Signed by Judge Sherry R. Fallon on 6/15/2020. (lih) |
| Jun 15, 2020 | 205 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Thomas Sarakatsannis on 6/22/2020 (Amended) filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 15, 2020 | 206 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Roy Diaz on 6/18/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 15, 2020 | 207 | Motion for Miscellaneous Relief (3) Docket Text: MOTION to Resolve Discovery Dispute - filed by Carmel Laboratories, LLC, University of Massachusetts. Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Jun 15, 2020 | 208 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Amended Initial Disclosures filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 12, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [202] Stipulation to Amend Scheduling Order filed by University of Massachusetts, Carmel Laboratories, LLC. Ordered by Judge Colm F. Connolly on 6/12/2020. (fms) |
| Jun 12, 2020 | 203 | Redacted Document (1) Docket Text: REDACTED VERSION of [198] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-5)(Farnan, Brian) |
| Jun 12, 2020 | 203 | Exhibits 1-5 (26) |
| Jun 12, 2020 | 204 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of L'Oral USA, Inc. on June 19, 2020 filed by Carmel Laboratories, LLC.(Farnan, Brian) |
| Jun 12, 2020 | 203 | Redacted Document (Main Document) (1) Docket Text: REDACTED VERSION of [198] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-5)(Farnan, Brian) |
| Jun 12, 2020 | 203 | Redacted Document (Exhibits 1-5) (26) Docket Text: REDACTED VERSION of [198] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-5)(Farnan, Brian) |
| Jun 11, 2020 | 202 | Stipulation (3) Docket Text: STIPULATION to Amend the Scheduling Order by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Jun 8, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Nicholas C. Carullo for Carmel Laboratories, LLC,Nicholas C. Carullo for University of Massachusetts added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Jun 8, 2020 | 201 | Memorandum and Order (6) Docket Text: MEMORANDUM ORDER OVERRULING [151] Objections, filed by L'Oreal USA, Inc. Signed by Judge Colm F. Connolly on 6/8/2020. (nmf) |
| Jun 5, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Plaintiff is directed to file exhibits that correspond to the exhibits cited in its response to Defendant's objections to the Magistrate Judge's April 24, 2020 order (D.I. [177]). For example, Plaintiff cites "Ex. 1," which is apparently the transcript of the April 24th hearing. The Court was able to find that transcript (as it was attached as an exhibit to Defendants filing). But Plaintiff cites to other transcripts (e.g., "Ex. 3," cited on page 5 of D.I. [177]) that the Court cannot locate. Ordered by Judge Colm F. Connolly on 6/5/2020. (nmf) |
| Jun 5, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: There being no good cause to justify the sealing of D.I. [151] or the redactions in D.I. [168], it is HEREBY ORDERED that D.I. [151] is UNSEALED. The parties shall confer and take steps to unseal and/or unredact by no later than June 30, 2020 all other docket filings for which there is no good cause to justify sealing or redactions. Ordered by Judge Colm F. Connolly on 6/5/2020. (nmf) |
| Jun 5, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [199] MOTION for Pro Hac Vice Appearance of Attorney Nicholas C. Carullo filed by University of Massachusetts, Carmel Laboratories, LLC. Signed by Judge Colm F. Connolly on 6/5/2020. (fms) |
| Jun 5, 2020 | 199 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nicholas C. Carullo - filed by Carmel Laboratories, LLC, University of Massachusetts. Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Jun 5, 2020 | 200 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Fourth Supplemental Responses and Objections to Defendant's First Set of Interrogatories and the corresponding Notice of Service filed by University of Massachusetts.(Farnan, Brian) |
| Jun 3, 2020 | 180 | Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of L'Oreal USA, Inc. on 6/11/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 3, 2020 | 181 | Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of L'Oreal USA, Inc. on 6/12/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 3, 2020 | 182 | Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of L'Oreal USA, Inc. on 6/12/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 3, 2020 | 183 | Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of L'Oreal USA, Inc. on 6/15/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 3, 2020 | 184 | Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of L'Oreal USA, Inc. on 6/15/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 3, 2020 | 185 | Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of L'Oreal USA, Inc. on 6/15/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 3, 2020 | 186 | Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of L'Oreal USA, Inc. on 6/16/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 3, 2020 | 187 | Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of L'Oreal USA, Inc. on 6/17/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 3, 2020 | 188 | Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of L'Oreal USA, Inc. on 6/19/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 3, 2020 | 189 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Ali Goldstein on 6/18/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 3, 2020 | 190 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Angelike Galdi on 6/12/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 3, 2020 | 191 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Jean-Baptiste Galey on 6/16/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 3, 2020 | 192 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Megan Grant on 6/19/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 3, 2020 | 193 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Paula Cziryak on 6/18/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 3, 2020 | 194 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Thomas Sarakatsannis on 6/15/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 3, 2020 | 195 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of L'Oreal USA, Inc. on 6/17/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 3, 2020 | 196 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Amended Initial Disclosures filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jun 3, 2020 | 197 | Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of L'Oreal USA, Inc. on 6/16/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| May 27, 2020 | 179 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Subpoena to Testify at a Deposition to Heather A. Steinman and (2) Subpoena to Testify at a Deposition to David Warshawsky filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| May 22, 2020 | 176 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Third Supplemental Responses and Objections to Defendant's First Set of Interrogatories filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| May 22, 2020 | 178 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant L'Oreal USA, Inc.'s: (1) Objections and Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-50); (2) Objections and Responses to Plaintiffs' Fifth Set of Interrogatories (Nos. 18-25); and (3) First Supplemental Objections and Response to Plaintiffs' Interrogatory No. 9 filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| May 21, 2020 | 173 | Redacted Document (5) Docket Text: REDACTED VERSION of [163] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-10)(Farnan, Brian) |
| May 21, 2020 | 173 | Exhibits 1-10 (64) |
| May 21, 2020 | 174 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant L'Oreal USA, Inc.'s: (1) First Supplemental Objections and Response to Plaintiffs' Interrogatory No. 14; and (2) Corrected First Supplemental Objections and Responses to Plaintiffs' Requests for Production of Documents No. 27, 32, 40-42, 53, 59 and 66 filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| May 21, 2020 | 175 | Redacted Document (30) Docket Text: REDACTED VERSION of [164] Letter by L'Oreal USA, Inc.. (Cottrell, Frederick) |
| May 21, 2020 | 173 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [163] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-10)(Farnan, Brian) |
| May 21, 2020 | 173 | Redacted Document (Exhibits 1-10) (30) Docket Text: REDACTED VERSION of [163] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-10)(Farnan, Brian) |
| May 20, 2020 | 171 | Redacted Document (5) Docket Text: REDACTED VERSION of [160] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B-P)(Mowery, Katharine) |
| May 20, 2020 | 171 | Exhibit A (3) |
| May 20, 2020 | 171 | Exhibit B-P (121) |
| May 20, 2020 | 172 | Redacted Document (5) Docket Text: REDACTED VERSION of [159] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-U)(Farnan, Brian) |
| May 20, 2020 | 172 | Exhibits A-U (164) |
| May 20, 2020 | 171 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [160] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B-P)(Mowery, Katharine) |
| May 20, 2020 | 171 | Redacted Document (Exhibit A) (3) Docket Text: REDACTED VERSION of [160] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B-P)(Mowery, Katharine) |
| May 20, 2020 | 171 | Redacted Document (Exhibit B-P) (30) Docket Text: REDACTED VERSION of [160] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B-P)(Mowery, Katharine) |
| May 20, 2020 | 172 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [159] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-U)(Farnan, Brian) |
| May 20, 2020 | 172 | Redacted Document (Exhibits A-U) (30) Docket Text: REDACTED VERSION of [159] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-U)(Farnan, Brian) |
| May 19, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER- The court shall conduct a discovery status teleconference on June 23, 2020 at 2:00 PM. On or before noon on June 15, 2020, the parties shall submit a Joint Motion to Resolve a Discovery Dispute outlining the proposed agenda for issues to be raised during the June 23, 2020 teleconference and specifying whether simultaneous submissions are requested. Issues included in the Joint Motion which exceed the scope of the issues raised during the May 18, 2020 discovery dispute teleconference shall be separately identified, however, each side is limited to a total number of three (3) issues, regardless of whether such issues are considered new or carryover issues. Leave of Court is required prior to briefing issues exceeding the scope of those raised during the May 18, 2020 discovery dispute teleconference. Ordered by Judge Sherry R. Fallon on 5/19/2020. (lih) |
| May 19, 2020 | 169 | Redacted Document (4) Docket Text: REDACTED VERSION of [155] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-D)(Cottrell, Frederick) |
| May 19, 2020 | 169 | Exhibit A-D (17) |
| May 19, 2020 | 170 | Redacted Document (4) Docket Text: REDACTED VERSION of [156] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-T)(Farnan, Michael) |
| May 19, 2020 | 170 | Exhibits A-T (210) |
| May 19, 2020 | 169 | Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [155] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-D)(Cottrell, Frederick) |
| May 19, 2020 | 169 | Redacted Document (Exhibit A-D) (17) Docket Text: REDACTED VERSION of [155] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-D)(Cottrell, Frederick) |
| May 19, 2020 | 170 | Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [156] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-T)(Farnan, Michael) |
| May 19, 2020 | 170 | Redacted Document (Exhibits A-T) (30) Docket Text: REDACTED VERSION of [156] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-T)(Farnan, Michael) |
| May 18, 2020 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Sherry R. Fallon - Discovery Dispute Telephone Conference held on 5/18/2020. (Court Reporter V. Gunning.) (lih) |
| May 18, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Karthik R. Kasaraneni for L'Oreal USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| May 18, 2020 | 168 | Redacted Document (25) Docket Text: REDACTED VERSION of [151] Objections by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance, # (2) Certification to Objections)(Mowery, Katharine) |
| May 18, 2020 | 168 | Certificate of Compliance (1) |
| May 18, 2020 | 168 | Certification to Objections (3) |
| May 18, 2020 | 168 | Redacted Document (Main Document) (25) Docket Text: REDACTED VERSION of [151] Objections by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance, # (2) Certification to Objections)(Mowery, Katharine) |
| May 18, 2020 | 168 | Redacted Document (Certificate of Compliance) (1) Docket Text: REDACTED VERSION of [151] Objections by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance, # (2) Certification to Objections)(Mowery, Katharine) |
| May 18, 2020 | 168 | Redacted Document (Certification to Objections) (3) Docket Text: REDACTED VERSION of [151] Objections by L'Oreal USA, Inc.. (Attachments: # (1) Certificate of Compliance, # (2) Certification to Objections)(Mowery, Katharine) |
| May 15, 2020 | 167 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Supplemental Responses and Objections to Defendant's First Set of Interrogatories filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| May 14, 2020 | 165 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Blaine M.Hackman as co-counsel.. (Mowery, Katharine) |
| May 14, 2020 | 166 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Revised Privilege Log filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| May 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED- re [157] MOTION for Pro Hac Vice Appearance of Attorney Davida Brook. Signed by Judge Sherry R. Fallon on 5/13/2020. (lih) |
| May 13, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The notice of service previously filed as D.I. 158 has been deleted per the request of counsel. The document will be re-filed shortly. (lih) |
| May 13, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Davida Brook for Carmel Laboratories, LLC and University of Massachusetts added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| May 13, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER- Due to a conflict with the courts calendar, IT IS HEREBY ORDERED that the discovery dispute teleconference previously set in this matter for 5/18/2020 at 11:00 AM is RESCHEDULED to 09:00 AM before Judge Sherry R. Fallon. Ordered by Judge Sherry R. Fallon on 5/13/2020. (lih) |
| May 13, 2020 | 157 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Davida Brook - filed by Carmel Laboratories, LLC, University of Massachusetts. Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| May 13, 2020 | 158 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Subpoena to Testify at a Deposition in a Civil Action to Frank Gallagher filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| May 13, 2020 | 161 | Redacted Document (4) Docket Text: REDACTED VERSION of [148] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-4)(Farnan, Brian) |
| May 13, 2020 | 161 | Exhibits 1-4 (32) |
| May 13, 2020 | 162 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Katharine L. Mowery regarding courtesy copies of the Objections to Magistrate Judge's April 24, 2020 Order - re [151] Objections. (Mowery, Katharine) |
| May 13, 2020 | 161 | Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [148] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-4)(Farnan, Brian) |
| May 13, 2020 | 161 | Redacted Document (Exhibits 1-4) (30) Docket Text: REDACTED VERSION of [148] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-4)(Farnan, Brian) |
| May 12, 2020 | 154 | Redacted Document (7) Docket Text: REDACTED VERSION of [144] Letter by L'Oreal USA, Inc.. (Mowery, Katharine) Modified on 5/13/2020 (lih). |
| May 11, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER- re [153] Joint MOTION to Resolve Discovery Dispute. IT IS HEREBY ORDERED that for issues raised on the April 24, 2020 teleconference, each side shall simultaneously submit letter briefs limited to three (3) pages by May 12, 2020. For issues not raised on the April 24, 2020 teleconference, the parties shall submit letter briefing pursuant to the Courts Order on Discovery Matters, with opening letters submitted by no later than noon on May 13, 2020 and answering letters submitted by no later than noon on May 14, 2020. Ordered by Judge Sherry R. Fallon on 5/11/2020. (lih) |
| May 11, 2020 | 152 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Second Supplemental Objections and responses to Plaintiffs Interrogatory Nos. 1, 3, 5 and 6; (2) First Supplemental Objections and Responses to Plaintiffs Interrogatory No. 12; (3) First Supplemental Objections and responses to Plaintiffs Requests for Production of Documents Nos. 27, 32, 40-42, 53, 59 and 66; and (4) Objections and Responses to Plaintiffs Fourth Set of Interrogatories filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| May 11, 2020 | 153 | Motion for Miscellaneous Relief (3) Docket Text: Joint MOTION to Resolve Discovery Dispute - filed by Carmel Laboratories, LLC, University of Massachusetts. Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| May 8, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Dennis S. Ellis and Serli Polatoglu for L'Oreal USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| May 8, 2020 | 151 | Objections (14) Docket Text: OBJECTIONS by L'Oreal USA, Inc. to Magistrate Judge's April 24, 2020 Order. (Attachments: # (1) Exhibit A-B, # (2) Certificate of Compliance, # (3) Certification to Objections)(Cottrell, Frederick) Modified on 5/9/2020 (lih). Modified on 6/5/2020 (nmf). |
| May 8, 2020 | 151 | Exhibit A-B (11) |
| May 8, 2020 | 151 | Certificate of Compliance (1) |
| May 8, 2020 | 151 | Certification to Objections (3) |
| May 8, 2020 | 151 | Objections (Main Document) (14) Docket Text: OBJECTIONS by L'Oreal USA, Inc. to Magistrate Judge's April 24, 2020 Order. (Attachments: # (1) Exhibit A-B, # (2) Certificate of Compliance, # (3) Certification to Objections)(Cottrell, Frederick) Modified on 5/9/2020 (lih). Modified on 6/5/2020 (nmf). |
| May 8, 2020 | 151 | Objections (Exhibit A-B) (11) Docket Text: OBJECTIONS by L'Oreal USA, Inc. to Magistrate Judge's April 24, 2020 Order. (Attachments: # (1) Exhibit A-B, # (2) Certificate of Compliance, # (3) Certification to Objections)(Cottrell, Frederick) Modified on 5/9/2020 (lih). Modified on 6/5/2020 (nmf). |
| May 8, 2020 | 151 | Objections (Certificate of Compliance) (1) Docket Text: OBJECTIONS by L'Oreal USA, Inc. to Magistrate Judge's April 24, 2020 Order. (Attachments: # (1) Exhibit A-B, # (2) Certificate of Compliance, # (3) Certification to Objections)(Cottrell, Frederick) Modified on 5/9/2020 (lih). Modified on 6/5/2020 (nmf). |
| May 8, 2020 | 151 | Objections (Certification to Objections) (3) Docket Text: OBJECTIONS by L'Oreal USA, Inc. to Magistrate Judge's April 24, 2020 Order. (Attachments: # (1) Exhibit A-B, # (2) Certificate of Compliance, # (3) Certification to Objections)(Cottrell, Frederick) Modified on 5/9/2020 (lih). Modified on 6/5/2020 (nmf). |
| May 7, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Having reviewed the parties letter submissions regarding Defendants request to extend the time for filing objections to the Courts April 24, 2020 discovery dispute ruling (D.I. [144]; D.I. [148]), IT IS HEREBY ORDERED that Defendants request (D.I. [144]) is DENIED. Any objections to the Courts April 24, 2020 discovery dispute rulings shall remain due on or before May 8, 2020. IT IS FURTHER ORDERED that Defendant shall be prepared to address the location and the volume of the documents, the efforts made to review the documents, and the anticipated timing of the document production and submission of a privilege log, if any, during the discovery dispute teleconference scheduled for May 18, 2020. Ordered by Judge Sherry R. Fallon on 5/7/2020. (lih) |
| May 7, 2020 | 149 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendant L'Oreal USA, Inc.'s Third Set of Requests for the Production of Documents and Things to Plaintiffs (Nos. 137-141) filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| May 7, 2020 | 150 | Notice (Other) (2) Docket Text: NOTICE of Change of Firm Affiliation by L'Oreal USA, Inc. (Mowery, Katharine) |
| May 6, 2020 | 147 | Letter (1) Docket Text: Letter to The Honorable Sherry R. Fallon from Brian E. Farnan regarding Response to Defendant's May 5, 2020 Letter - re [144] Letter. (Farnan, Brian) |
| May 5, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [139] Stipulation to Amend Scheduling Order filed by L'Oreal USA, Inc. See Stipulation for deadlines. Ordered by Judge Colm F. Connolly on 5/5/2020. (fms) |
| May 5, 2020 | 144 | Letter (2) Docket Text: Letter to The Honorable Sherry R. Fallon from Frederck L. Cottrell III regarding Request for Extension of Time to Object. (Attachments: # (1) Exhibit A)(Cottrell, Frederick) Modified on 7/23/2020 (nmf). |
| May 5, 2020 | 144 | Exhibit A (5) |
| May 5, 2020 | 145 | Proposed Order (1) Docket Text: PROPOSED ORDER to extend the deadline to file Objections re [144] Letter by L'Oreal USA, Inc.. (Cottrell, Frederick) |
| May 5, 2020 | 146 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant L'Oreal USA's: (1) Subpoena to Testify at a Deposition in a Civil Action to Teresian Carmelites, Inc.; (2) Subpoena to Testify at a Deposition in a Civil Action to Paul Menard; (3) Subpoena to Testify at a Deposition in a Civil Action to Renato Jose; (4) Subpoena to Testify at a Deposition in a Civil Action to James G. Dobson, Jr.; and (5) Subpoena to Testify at a Deposition in a Civil Action to Michael F. Ethier filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| May 5, 2020 | 144 | Letter (Main Document) (2) Docket Text: Letter to The Honorable Sherry R. Fallon from Frederck L. Cottrell III regarding Request for Extension of Time to Object. (Attachments: # (1) Exhibit A)(Cottrell, Frederick) Modified on 7/23/2020 (nmf). |
| May 5, 2020 | 144 | Letter (Exhibit A) (5) Docket Text: Letter to The Honorable Sherry R. Fallon from Frederck L. Cottrell III regarding Request for Extension of Time to Object. (Attachments: # (1) Exhibit A)(Cottrell, Frederick) Modified on 7/23/2020 (nmf). |
| May 4, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Removed STIPULATION and [Proposed] Order per request of counsel, (wrong filer selected). (rwc) |
| May 4, 2020 | 138 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Responses and Objections to Defendant's First Set of Interrogatories filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| May 4, 2020 | 139 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order to Amend Scheduling Order by L'Oreal USA, Inc.. (Mowery, Katharine) |
| May 4, 2020 | 140 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dennis Wyrzykowski on a date, time and location that is mutually agreeable to the parties filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| May 4, 2020 | 141 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Satinder Rawat on a date, time and location that is mutually agreeable to the parties filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| May 4, 2020 | 142 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of James McNamara on a date, time and location that is mutually agreeable to the parties filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| May 4, 2020 | 143 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Kevin Lehman on a date, time and location that is mutually agreeable to the parties filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Apr 29, 2020 | 136 | Redacted Document (5) Docket Text: REDACTED VERSION of [127] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-7)(Farnan, Brian) |
| Apr 29, 2020 | 136 | Exhibits 1-7 (25) |
| Apr 29, 2020 | 137 | Redacted Document (3) Docket Text: REDACTED VERSION of [126] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A)(Cottrell, Frederick) Modified on 4/30/2020 (lih). |
| Apr 29, 2020 | 137 | Exhibit A (1) |
| Apr 29, 2020 | 136 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [127] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-7)(Farnan, Brian) |
| Apr 29, 2020 | 136 | Redacted Document (Exhibits 1-7) (25) Docket Text: REDACTED VERSION of [127] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-7)(Farnan, Brian) |
| Apr 29, 2020 | 137 | Redacted Document (Main Document) (3) Docket Text: REDACTED VERSION of [126] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A)(Cottrell, Frederick) Modified on 4/30/2020 (lih). |
| Apr 29, 2020 | 137 | Redacted Document (Exhibit A) (1) Docket Text: REDACTED VERSION of [126] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A)(Cottrell, Frederick) Modified on 4/30/2020 (lih). |
| Apr 28, 2020 | 134 | Redacted Document (9) Docket Text: REDACTED VERSION of [125] Exhibit to a Document by L'Oreal USA, Inc.. (Mowery, Katharine) Modified on 4/29/2020 (lih). |
| Apr 28, 2020 | 135 | Redacted Document (4) Docket Text: REDACTED VERSION of [123] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-9)(Farnan, Brian) |
| Apr 28, 2020 | 135 | Exhibits 1-9 (40) |
| Apr 28, 2020 | 135 | Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [123] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-9)(Farnan, Brian) |
| Apr 28, 2020 | 135 | Redacted Document (Exhibits 1-9) (30) Docket Text: REDACTED VERSION of [123] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-9)(Farnan, Brian) |
| Apr 27, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER- The court shall conduct a discovery status teleconference on May 18, 2020 at 11:00 AM. On or before noon on May 11, 2020, the parties shall submit a Joint Motion to Resolve a Discovery Dispute outlining the proposed agenda for issues to be raised during the May 18, 2020 teleconference and specifying whether simultaneous submissions are requested. Issues included in the Joint Motion which exceed the scope of the issues raised during the April 24, 2020 discovery dispute teleconference shall be separately identified. Leave of Court is required prior to briefing issues exceeding the scope of those raised during the April 24, 2020 discovery dispute teleconference. Ordered by Judge Sherry R. Fallon on 4/27/2020. Signed by Judge Sherry R. Fallon on 4/27/2020. (lih) |
| Apr 27, 2020 | 131 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Amended Disclosures filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Apr 27, 2020 | 132 | Redacted Document (4) Docket Text: REDACTED VERSION of [120] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-24, # (2) Text of Proposed Order)(Farnan, Brian) |
| Apr 27, 2020 | 132 | Exhibits 1-24 (178) |
| Apr 27, 2020 | 132 | Text of Proposed Order (2) |
| Apr 27, 2020 | 133 | Redacted Document (4) Docket Text: REDACTED VERSION of [121] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-J)(Cottrell, Frederick) Modified on 4/28/2020 (lih). |
| Apr 27, 2020 | 133 | Exhibit A-J (60) |
| Apr 27, 2020 | 132 | Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [120] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-24, # (2) Text of Proposed Order)(Farnan, Brian) |
| Apr 27, 2020 | 132 | Redacted Document (Exhibits 1-24) (30) Docket Text: REDACTED VERSION of [120] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-24, # (2) Text of Proposed Order)(Farnan, Brian) |
| Apr 27, 2020 | 132 | Redacted Document (Text of Proposed Order) (2) Docket Text: REDACTED VERSION of [120] Letter,, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits 1-24, # (2) Text of Proposed Order)(Farnan, Brian) |
| Apr 27, 2020 | 133 | Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [121] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-J)(Cottrell, Frederick) Modified on 4/28/2020 (lih). |
| Apr 27, 2020 | 133 | Redacted Document (Exhibit A-J) (30) Docket Text: REDACTED VERSION of [121] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-J)(Cottrell, Frederick) Modified on 4/28/2020 (lih). |
| Apr 24, 2020 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Sherry R. Fallon - Discovery Dispute Telephone Conference held on 4/24/2020. (Court Reporter S. Ingram (Hawkins Reporting).) (lih) |
| Apr 24, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER- IT IS HEREBY ORDERED that the transcript of the 4/24/2020 discovery dispute hearing shall serve as the order of the court. Signed by Judge Sherry R. Fallon on 4/24/2020. (lih) |
| Apr 24, 2020 | 130 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to L'Oreal's Notice of Deposition filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Apr 23, 2020 | 129 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant L'Oreal USA Inc.'s Third Set of Requests for the Production of Documents and Things to Plaintiffs (Nos. 137-141) filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Apr 22, 2020 | 128 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) University of Massachusetts and Carmel Laboratories, LLC's First Set of Requests for Admission to Defendant L'Oreal USA, Inc. and (ii) University of Massachusetts and Carmel Laboratories, LLC's Fifth Set of Interrogatories to Defendant L'Oreal USA, Inc. filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Apr 21, 2020 | 124 | Letter (3) Docket Text: Letter to The Honorable Sherry R. Fallon from Frederick L. Cottrell, III regarding Discovery Disputes Previously Raised on March 26, 2020 Teleconference. (Attachments: # (1) Exhibit A, B and D)(Cottrell, Frederick) |
| Apr 21, 2020 | 124 | Exhibit A, B and D (35) |
| Apr 21, 2020 | 125 | Exhibit to a Document (2) Docket Text: EXHIBIT re [124] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit C)(Cottrell, Frederick) Modified on 7/23/2020 (nmf). |
| Apr 21, 2020 | 125 | Exhibit C (7) |
| Apr 21, 2020 | 124 | Letter (Main Document) (3) Docket Text: Letter to The Honorable Sherry R. Fallon from Frederick L. Cottrell, III regarding Discovery Disputes Previously Raised on March 26, 2020 Teleconference. (Attachments: # (1) Exhibit A, B and D)(Cottrell, Frederick) |
| Apr 21, 2020 | 124 | Letter (Exhibit A, B and D) (30) Docket Text: Letter to The Honorable Sherry R. Fallon from Frederick L. Cottrell, III regarding Discovery Disputes Previously Raised on March 26, 2020 Teleconference. (Attachments: # (1) Exhibit A, B and D)(Cottrell, Frederick) |
| Apr 21, 2020 | 125 | Exhibit to a Document (Main Document) (2) Docket Text: EXHIBIT re [124] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit C)(Cottrell, Frederick) Modified on 7/23/2020 (nmf). |
| Apr 21, 2020 | 125 | Exhibit to a Document (Exhibit C) (7) Docket Text: EXHIBIT re [124] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit C)(Cottrell, Frederick) Modified on 7/23/2020 (nmf). |
| Apr 20, 2020 | 119 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Objections and Responses to Plaintiffs' April 15, 2020 Notice of Deposition filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Apr 20, 2020 | 122 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant L'Oreal USA's Supplemental Objections and Responses to Plaintiffs' Interrogatory Nos. 7, 8 filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Apr 17, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER- re [118] MOTION to Resolve Discovery Dispute. IT IS HEREBY ORDERED that for issues raised on the March 26, 2020 teleconference, each side shall simultaneously submit letter briefs limited to three (3) pages by April 21, 2020. For issues not raised on the March 26, 2020 teleconference, the parties shall submit letter briefing pursuant to the Courts Order on Discovery Matters, with opening letters submitted April 20, 2020 and answering letters submitted April 22, 2020. Ordered by Judge Sherry R. Fallon on 4/17/2020. (lih) |
| Apr 17, 2020 | 118 | Motion for Miscellaneous Relief (3) Docket Text: MOTION to Resolve Discovery Dispute - filed by Carmel Laboratories, LLC, University of Massachusetts. Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Apr 15, 2020 | 117 | Notice to Take Deposition (6) Docket Text: NOTICE to Take Deposition of L'Oreal USA, Inc. on 4/23/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Apr 14, 2020 | 116 | Notice (Other) (2) Docket Text: NOTICE of Change of Firm Affiliation by L'Oreal USA, Inc. (Mowery, Katharine) |
| Apr 10, 2020 | 115 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant LOreal USAs Objections and Responses to Plaintiffs Notice of Deposition Pursuant to Rule 30(b)(6) filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Apr 9, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Per the request of Defendants' counsel, the Discovery Status Teleconference set in this matter for April 21, 2020 at 3:30 p.m. is RESCHEDULED to April 24, 2020 at 11:00 a.m. On or before noon on April 17, 2020, the parties shall submit a Joint Motion to Resolve a Discovery Dispute outlining the proposed agenda for issues to be raised during the April 24, 2020 teleconference and specifying whether simultaneous submissions are requested. Issues included in the Joint Motion which exceed the scope of the issues raised during the March 26, 2020 discovery dispute teleconference shall be separately identified. Leave of Court is required prior to briefing issues exceeding the scope of those raised during the March 26, 2020 discovery dispute teleconference. Ordered by Judge Sherry R. Fallon on 4/9/2020. (lih) |
| Apr 9, 2020 | 114 | Order (1) Docket Text: CLAIM CONSTRUCTION ORDER re [113] Proposed Claim Construction Order. Signed by Judge Colm F. Connolly on 4/9/2020. (nmf) |
| Apr 8, 2020 | 111 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of L'Oreal USA's Notice of Deposition of Plaintiffs filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Apr 8, 2020 | 112 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of University of Massachusetts and Carmel Laboratories, LLC's Fourth Set of Interrogatories to Defendant L'Oreal USA, Inc. filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Apr 8, 2020 | 113 | Proposed Order (1) Docket Text: PROPOSED ORDER Proposed Claim Construction Order by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Farnan, Brian) |
| Apr 8, 2020 | 113 | Letter to The Honorable Colm F. Connolly (1) |
| Apr 8, 2020 | 113 | Proposed Order (Main Document) (1) Docket Text: PROPOSED ORDER Proposed Claim Construction Order by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Farnan, Brian) |
| Apr 8, 2020 | 113 | Proposed Order (Letter to The Honorable Colm F. Connolly) (1) Docket Text: PROPOSED ORDER Proposed Claim Construction Order by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Farnan, Brian) |
| Apr 6, 2020 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Markman Hearing held on 4/6/2020. (Court Reporter V. Gunning.) (nmf) |
| Apr 3, 2020 | N/A | Set Deadlines/Hearings (0) Docket Text: Reset Hearings: The Markman Hearing will proceed telephonically on 4/6/2020 at 09:15 AM before Judge Colm F. Connolly. (nmf) |
| Mar 30, 2020 | 110 | Redacted Document (5) Docket Text: REDACTED VERSION of [105] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-J)(Mowery, Katharine) |
| Mar 30, 2020 | 110 | Exhibit A-J (30) |
| Mar 30, 2020 | 110 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [105] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-J)(Mowery, Katharine) |
| Mar 30, 2020 | 110 | Redacted Document (Exhibit A-J) (30) Docket Text: REDACTED VERSION of [105] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-J)(Mowery, Katharine) |
| Mar 26, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER- IT IS HEREBY ORDERED that the discovery dispute teleconference previously set in this matter for 11:00 AM is RESCHEDULED to 11:20 AM. The court will use an AT&T teleconferencing system for this call. The instructions are as follows: dial-in number- 8882733658; access code- 4305895 followed by the pound sign (#). Ordered by Judge Sherry R. Fallon on 3/26/2020. (lih) |
| Mar 26, 2020 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Sherry R. Fallon - Discovery Dispute Telephone Conference held on 3/26/2020. (Court Reporter V. Gunning.) (lih) |
| Mar 26, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER- re [100] Joint MOTION for Discovery Dispute Teleconference. The transcript of the discovery dispute teleconference held on 3/26/2020 shall serve as the order of the court. IT IS FURTHER ORDERED that the court shall conduct a status teleconference on 4/21/2020 at 03:30 PM before Judge Sherry R. Fallon. The court will use an AT&T teleconferencing system for this call. The instructions are as follows: dial-in number- 8882733658; access code- 4305895 followed by the pound sign (#).Ordered by Judge Sherry R. Fallon on 3/26/2020. (lih) |
| Mar 26, 2020 | 109 | Redacted Document (5) Docket Text: REDACTED VERSION of [103] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order, # (2) Exhibits A-L)(Farnan, Brian) |
| Mar 26, 2020 | 109 | Text of Proposed Order (2) |
| Mar 26, 2020 | 109 | Exhibits A-L (71) |
| Mar 26, 2020 | 109 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [103] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order, # (2) Exhibits A-L)(Farnan, Brian) |
| Mar 26, 2020 | 109 | Redacted Document (Text of Proposed Order) (2) Docket Text: REDACTED VERSION of [103] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order, # (2) Exhibits A-L)(Farnan, Brian) |
| Mar 26, 2020 | 109 | Redacted Document (Exhibits A-L) (30) Docket Text: REDACTED VERSION of [103] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Text of Proposed Order, # (2) Exhibits A-L)(Farnan, Brian) |
| Mar 23, 2020 | 108 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant L'Oreal USA, Inc.'s Privilege Log filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Mar 20, 2020 | 106 | Letter (3) Docket Text: Letter to The Honorable Sherry R. Fallon from Michael J. Farnan - re [104] Letter. (Attachments: # (1) Exhibit M)(Farnan, Michael) Modified on 3/23/2020 (lih). |
| Mar 20, 2020 | 106 | Exhibit M (2) |
| Mar 20, 2020 | 107 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Plaintiffs' Amended Initial Disclosures.; (ii) Plaintiffs' Responses and Objections to Defendant's First Set of Interrogatories; and (iii) Plaintiffs' Privilege Log filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Michael) |
| Mar 20, 2020 | 106 | Letter (Main Document) (3) Docket Text: Letter to The Honorable Sherry R. Fallon from Michael J. Farnan - re [104] Letter. (Attachments: # (1) Exhibit M)(Farnan, Michael) Modified on 3/23/2020 (lih). |
| Mar 20, 2020 | 106 | Letter (Exhibit M) (2) Docket Text: Letter to The Honorable Sherry R. Fallon from Michael J. Farnan - re [104] Letter. (Attachments: # (1) Exhibit M)(Farnan, Michael) Modified on 3/23/2020 (lih). |
| Mar 19, 2020 | 104 | Letter (2) Docket Text: Letter to The Honorable Sherry R. Fallon from Frederick L. Cottrell, III regarding Discovery Dispute. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A-B)(Cottrell, Frederick) |
| Mar 19, 2020 | 104 | Text of Proposed Order (1) |
| Mar 19, 2020 | 104 | Exhibit A-B (56) |
| Mar 19, 2020 | 104 | Letter (Main Document) (2) Docket Text: Letter to The Honorable Sherry R. Fallon from Frederick L. Cottrell, III regarding Discovery Dispute. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A-B)(Cottrell, Frederick) |
| Mar 19, 2020 | 104 | Letter (Text of Proposed Order) (1) Docket Text: Letter to The Honorable Sherry R. Fallon from Frederick L. Cottrell, III regarding Discovery Dispute. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A-B)(Cottrell, Frederick) |
| Mar 19, 2020 | 104 | Letter (Exhibit A-B) (30) Docket Text: Letter to The Honorable Sherry R. Fallon from Frederick L. Cottrell, III regarding Discovery Dispute. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A-B)(Cottrell, Frederick) |
| Mar 18, 2020 | 102 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant L'Oreal USA, Inc.s Supplemental Objections and Responses to Plaintiffs Interrogatory No. 11 filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Mar 17, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED- re [100] Joint MOTION for Discovery Dispute Teleconference. A Telephone Conference is set for 3/26/2020 at 11:00 AM before Judge Sherry R. Fallon. The court will use an AT&T teleconferencing system for this call. The instructions are as follows: dial-in number- 8882733658; access code- 4305895 followed by the pound sign (#). In preparation for this hearing the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Order regarding discovery matters available at www.ded.uscourts.gov/judge/magistrate-judge-sherry-r-fallon. Counsel is advised to the review the courts standing order entered on 3/13/2020 regarding paper courtesy copies. Set Deadlines: Moving submission due by no later than 11:00 AM on 3/19/2020; Responsive submission due by no later than 11:00 AM on 3/20/2020.) Signed by Judge Sherry R. Fallon on 3/17/2020. (lih) |
| Mar 13, 2020 | 100 | Motion for Discovery (2) Docket Text: Joint MOTION for Discovery Dispute Teleconference - filed by Carmel Laboratories, LLC. Motions referred to Sherry R. Fallon.(Farnan, Brian) Modified on 3/16/2020 (lih). |
| Mar 13, 2020 | 101 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant L'Oreal USA, Inc.'s Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Rule 30(b)(6) Topics 1-40 and 49 filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Mar 9, 2020 | 99 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant L'Oreal USA, Inc.'s Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Rule 30(b)(6) filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Mar 6, 2020 | 97 | Joint Claim Construction Brief (30) Docket Text: JOINT CLAIM CONSTRUCTION BRIEF filed by University of Massachusetts, Carmel Laboratories, LLC. (Farnan, Brian) |
| Mar 6, 2020 | 98 | Appendix (30) Docket Text: APPENDIX re [97] Joint Claim Construction Brief by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Mar 4, 2020 | 96 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant L'Oreal USA, Inc.'s Sur-Reply Claim Construction Brief filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Feb 21, 2020 | N/A | Redaction Notice (0) Docket Text: REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # [89]. (lih) |
| Feb 21, 2020 | 94 | Redacted Document (6) Docket Text: REDACTED VERSION of [89] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibits A-D)(Cottrell, Frederick) |
| Feb 21, 2020 | 94 | Exhibits A-D (44) |
| Feb 21, 2020 | 95 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of L'Oreal USA, Inc. on 3/12/2020 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Feb 21, 2020 | 94 | Redacted Document (Main Document) (6) Docket Text: REDACTED VERSION of [89] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibits A-D)(Cottrell, Frederick) |
| Feb 21, 2020 | 94 | Redacted Document (Exhibits A-D) (30) Docket Text: REDACTED VERSION of [89] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibits A-D)(Cottrell, Frederick) |
| Feb 20, 2020 | 93 | Redacted Document (4) Docket Text: REDACTED VERSION of [90] Letter by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits N-P)(Farnan, Brian) |
| Feb 20, 2020 | 93 | Exhibits N-P (19) |
| Feb 20, 2020 | 93 | Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [90] Letter by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits N-P)(Farnan, Brian) |
| Feb 20, 2020 | 93 | Redacted Document (Exhibits N-P) (19) Docket Text: REDACTED VERSION of [90] Letter by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits N-P)(Farnan, Brian) |
| Feb 19, 2020 | 91 | Redacted Document (5) Docket Text: REDACTED VERSION of [88] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-M)(Farnan, Brian) |
| Feb 19, 2020 | 91 | Exhibits A-M (101) |
| Feb 19, 2020 | 92 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of First Set of Interrogatories (Nos. 1-15) filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Feb 19, 2020 | 91 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [88] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-M)(Farnan, Brian) |
| Feb 19, 2020 | 91 | Redacted Document (Exhibits A-M) (30) Docket Text: REDACTED VERSION of [88] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-M)(Farnan, Brian) |
| Feb 18, 2020 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Sherry R. Fallon - Discovery Dispute Telephone Conference held on 2/18/2020. (Court Reporter J. Guy.) (lih) |
| Feb 18, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: For the reasons stated on the record during the February 18, 2020 discovery dispute teleconference, IT IS HEREBY ORDERED that Defendant shall produce all outstanding technical and financial information for each of the Accused Products, including officialization documents, formulation lists, product packaging, marketing materials, and product testing materials, on or before February 28, 2020. Ordered by Judge Sherry R. Fallon on 2/18/2020. (lih) |
| Feb 12, 2020 | 87 | Letter (4) Docket Text: Letter to The Honorable Sherry R. Fallon from Frederick L. Cottrell, III regarding discovery dispute. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A-G)(Cottrell, Frederick) |
| Feb 12, 2020 | 87 | Text of Proposed Order (1) |
| Feb 12, 2020 | 87 | Exhibit A-G (79) |
| Feb 12, 2020 | 87 | Letter (Main Document) (4) Docket Text: Letter to The Honorable Sherry R. Fallon from Frederick L. Cottrell, III regarding discovery dispute. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A-G)(Cottrell, Frederick) |
| Feb 12, 2020 | 87 | Letter (Text of Proposed Order) (1) Docket Text: Letter to The Honorable Sherry R. Fallon from Frederick L. Cottrell, III regarding discovery dispute. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A-G)(Cottrell, Frederick) |
| Feb 12, 2020 | 87 | Letter (Exhibit A-G) (30) Docket Text: Letter to The Honorable Sherry R. Fallon from Frederick L. Cottrell, III regarding discovery dispute. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A-G)(Cottrell, Frederick) |
| Feb 7, 2020 | 85 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendant LOreal USA, Inc.'s Second Set of Requests for the Production of Documents and Things to Plaintiffs (Nos. 132-136) filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Michael) |
| Feb 7, 2020 | 86 | Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of 30(b)(6) on An Agreed Upon Date filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Michael) |
| Feb 6, 2020 | 84 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Answering Claim Construction Brief filed by L'Oreal USA, Inc..(Cottrell, Frederick) |
| Feb 5, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [83] MOTION for Pro Hac Vice Appearance of Attorney Karthik R. Kasaraneni filed by L'Oreal USA, Inc. Signed by Judge Colm F. Connolly on 2/5/2020. (nmf) |
| Feb 5, 2020 | 83 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Karthik R. Kasaraneni - filed by L'Oreal USA, Inc.. Motions referred to Sherry R. Fallon.(Cottrell, Frederick) |
| Feb 4, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [82] MOTION to Resolve Discovery Disputes filed by University of Massachusetts, Carmel Laboratories, LLC. A Telephone Conference is set for 2/18/2020 at 01:00 PM before Judge Sherry R. Fallon. Plaintiffs shall initiate the call to 302-573-4557. In preparation for this hearing the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Order regarding discovery matters available at www.ded.uscourts.gov/judge/magistrate-judge-sherry-r-fallon. Set Deadlines: Moving submission due no later than 2/12/2020; Responsive submission due no later than 2/13/2020. Signed by Judge Sherry R. Fallon on 2/4/2020. (Polito, Rebecca) |
| Feb 4, 2020 | 82 | Motion for Miscellaneous Relief (2) Docket Text: MOTION to Resolve Discovery Disputes - filed by Carmel Laboratories, LLC, University of Massachusetts. Motions referred to Sherry R. Fallon.(Farnan, Michael) |
| Jan 17, 2020 | 81 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Objections and Responses to Third Set of Interrogatories and 2) Objections and Responses to Third Set of Requests for Production filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Jan 8, 2020 | 80 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Second Set of Requests for the Production of Documents and Things to Plaintiff's (Nos. 132-136) filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Dec 27, 2019 | N/A | Motions No Longer Referred (0) Docket Text: Motions No Longer Referred: [79] MOTION for Claim Construction re [77] Claim Construction Chart , [78] MOTION for Claim Construction (fms) |
| Dec 27, 2019 | 77 | Claim Construction Chart (7) Docket Text: CLAIM Construction Chart by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) `327 Patent, # (2) `531 Patent)(Farnan, Brian) |
| Dec 27, 2019 | 77 | `327 Patent (9) |
| Dec 27, 2019 | 77 | `531 Patent (11) |
| Dec 27, 2019 | 78 | Motion for Miscellaneous Relief (3) Docket Text: MOTION for Claim Construction - filed by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) Modified on 12/30/2019 (fms). |
| Dec 27, 2019 | 79 | Motion for Miscellaneous Relief (2) Docket Text: MOTION for Claim Construction re [77] Claim Construction Chart - filed by L'Oreal USA, Inc..(Mowery, Katharine) (fms). Modified on 12/30/2019 (fms). |
| Dec 27, 2019 | N/A | Motions No Longer Referred (0) Docket Text: Motions No Longer Referred: [79] MOTION for Claim Construction re [77] Claim Construction Chart , [78] MOTION for Claim Construction (fms) |
| Dec 27, 2019 | 77 | Claim Construction Chart (Main Document) (7) Docket Text: CLAIM Construction Chart by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) `327 Patent, # (2) `531 Patent)(Farnan, Brian) |
| Dec 27, 2019 | 77 | Claim Construction Chart (`327 Patent) (9) Docket Text: CLAIM Construction Chart by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) `327 Patent, # (2) `531 Patent)(Farnan, Brian) |
| Dec 27, 2019 | 77 | Claim Construction Chart (`531 Patent) (11) Docket Text: CLAIM Construction Chart by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) `327 Patent, # (2) `531 Patent)(Farnan, Brian) |
| Dec 23, 2019 | 76 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Notice of Proposed Claim Constructions filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Dec 20, 2019 | 75 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant L'Oreal USA, Inc.'s Proposed Term for Construction filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Dec 18, 2019 | 74 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) University of Massachusetts and Carmel Laboratories, LLC's Third Set of Interrogatories to Defendant L'Oreal USA, Inc. and (ii) University of Massachusetts and Carmel Laboratories, LLC's Third Set of Requests for Production of Documents to Defendant L'Oreal USA, Inc. filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Dec 16, 2019 | 73 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Amended Disclosure of Asserted Claims and Initial Infringement Contentions filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Dec 13, 2019 | 72 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant L'Oreal USA, Inc.'s Initial Invalidity Contentions filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Dec 11, 2019 | 71 | Redacted Document (4) Docket Text: REDACTED VERSION of [68] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit 1-13)(Mowery, Katharine) |
| Dec 11, 2019 | 71 | Exhibit 1-13 (96) |
| Dec 11, 2019 | 71 | Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [68] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit 1-13)(Mowery, Katharine) |
| Dec 11, 2019 | 71 | Redacted Document (Exhibit 1-13) (30) Docket Text: REDACTED VERSION of [68] Letter by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit 1-13)(Mowery, Katharine) |
| Dec 9, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER- Due to a conflict with the courts calendar, IT IS HEREBY ORDERED that the teleconference set in this matter for today at 2:00 PM is RESCHEDULED to 02:30 PM before Judge Sherry R. Fallon. Ordered by Judge Sherry R. Fallon on 12/9/2019. (lih) |
| Dec 9, 2019 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Sherry R. Fallon - Discovery Dispute Telephone Conference held on 12/9/2019. (Court Reporter S. Vickers (Hawkins Reporting).) (lih) |
| Dec 9, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER- re [62] MOTION for Teleconference to Resolve Discovery Disputes. The transcript of the 12/9/2019 discovery dispute teleconference shall serve as the order of the court. Ordered by Judge Sherry R. Fallon on 12/9/2019. (lih) |
| Dec 9, 2019 | 70 | Redacted Document (5) Docket Text: REDACTED VERSION of [69] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-F)(Farnan, Brian) |
| Dec 9, 2019 | 70 | Exhibits A-F (122) |
| Dec 9, 2019 | 70 | Redacted Document (Main Document) (5) Docket Text: REDACTED VERSION of [69] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-F)(Farnan, Brian) |
| Dec 9, 2019 | 70 | Redacted Document (Exhibits A-F) (30) Docket Text: REDACTED VERSION of [69] Letter, by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Exhibits A-F)(Farnan, Brian) |
| Dec 4, 2019 | 67 | Letter (1) Docket Text: Letter to The Honorable Sherry R. Fallon from Brian E. Farnan regarding Discovery Dispute. (Farnan, Brian) |
| Dec 3, 2019 | 66 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Corrected First Supplemental Objections and Responses to Plaintiffs' Interrogatory Nos. 1, 2, 3, 5 and 6 filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Dec 2, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [64] STIPULATION to Amend the Scheduling Order re 63 Stipulation [Corrected] (See stipulation for details.) Signed by Judge Colm F. Connolly on 12/2/2019. (nmf) |
| Dec 2, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED- re [62] MOTION for Teleconference to Resolve Discovery Disputes. A Telephone Conference is set for 12/9/2019 at 02:00 PM before Judge Sherry R. Fallon. Counsel for the plaintiff shall initiate the call to 302-573-4557. In preparation for this hearing the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Order regarding discovery matters available at www.ded.uscourts.gov/judge/magistrate-judge-sherry-r-fallon. Set Deadlines: Moving submission due by no later than 2:00 PM on 12/4/2019; Responsive submission due by no later than 2:00 PM on 12/5/2019.) Signed by Judge Sherry R. Fallon on 12/2/2019. (lih) |
| Nov 27, 2019 | 64 | Stipulation (2) Docket Text: STIPULATION to Amend the Scheduling Order re [63] Stipulation [Corrected] by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Nov 27, 2019 | 65 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of L'Oreal USA, Inc.'s First Supplemental Objections and Responses to Plaintiffs' Interrogatory Nos. 1, 2, 3, 5, and 6 filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Nov 25, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Isaac S. Ashkenazi for L'Oreal USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d), Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam) |
| Nov 22, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Nicholas A. Tymoczko, and Eric Dittmann for L'Oreal USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d), Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam) |
| Nov 22, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [63] STIPULATION and [Proposed] Order re [46] Scheduling Order. See stipulation for further details. Signed by Judge Colm F. Connolly on 11/22/2019. (nmf) |
| Nov 22, 2019 | 63 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order re [46] Scheduling Order,, by L'Oreal USA, Inc.. (Cottrell, Frederick) |
| Nov 21, 2019 | 62 | Motion for Miscellaneous Relief (2) Docket Text: MOTION for Teleconference to Resolve Discovery Disputes - filed by Carmel Laboratories, LLC, University of Massachusetts. Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Nov 20, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [61] MOTION for Pro Hac Vice Appearance of Attorney Eric W. Dittman, Isaac S. Ashkenazi, Nicholas A. Tymoczko and Serli Polatoglu filed by L'Oreal USA, Inc. Signed by Judge Colm F. Connolly on 11/20/2019. (fms) |
| Nov 20, 2019 | 61 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Eric W. Dittman, Isaac S. Ashkenazi, Nicholas A. Tymoczko and Serli Polatoglu - filed by L'Oreal USA, Inc.. Motions referred to Sherry R. Fallon.(Cottrell, Frederick) |
| Nov 15, 2019 | 60 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Supplemental Objections and Responses to Defendant L'Oreal USA, Inc.'s First Set of Requests for the Production of Documents and Things to Plaintiffs (Nos. 1-131) filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Oct 29, 2019 | 59 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Amended Disclosure of Asserted Claims and Initial Infringement Contentions filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Oct 15, 2019 | 58 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Objections and Responses to Plaintiffs' First Notice of Rule 30(b)(6) Deposition filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Oct 11, 2019 | 57 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendant LOral USA, Inc.'s First Set of Requests for the Production of Documents and Things to Plaintiffs (Nos. 1-131) filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Oct 10, 2019 | 56 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Plaintiffs' Disclosure of Asserted Claims and Initial Infringement Contentions and (ii) Plaintiffs' Identification of Documents Pursuant to Paragraph 4 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Oct 3, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Naveen Modi for L'Oreal USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Sep 20, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED- re [54] Stipulation Amending Disclosure Deadline, [48] Stipulated Protective Order. Signed by Judge Sherry R. Fallon on 9/20/2019. (lih) |
| Sep 20, 2019 | 55 | Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of L'Oreal USA, Inc. on 10/18/2019 filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Sep 19, 2019 | 54 | Stipulation (1) Docket Text: STIPULATION Amending Scheduling Order by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Sep 11, 2019 | 53 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendant L'Oreal USA, Inc.'s First Set of Requests for the Production of Documents and Things to Plaintiffs (Nos. 1-131) filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Sep 3, 2019 | 52 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Objections and Responses to First Set of Request for Production of Documents, 2) Objections and Responses to Second Set of Request for Production of Documents, 3) Objections and Responses to First Set of Interrogatories, and 4) Objections and Responses to Second Set of Interrogatories filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Aug 20, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [51] STIPULATION Amending Scheduling Order. Signed by Judge Colm F. Connolly on 8/20/2019. (nmf) |
| Aug 20, 2019 | 51 | Stipulation (1) Docket Text: STIPULATION Amending Scheduling Order by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) |
| Aug 19, 2019 | 48 | Proposed Order (17) Docket Text: PROPOSED Proposed Protective Order by Carmel Laboratories, LLC, University of Massachusetts. (Farnan, Brian) Modified on 9/19/2019 (lih). |
| Aug 19, 2019 | 49 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Aug 19, 2019 | 50 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant L'Oreal USA's Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) filed by L'Oreal USA, Inc..(Mowery, Katharine) |
| Jul 30, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak) |
| Jul 30, 2019 | 46 | Scheduling Order (20) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 8/23/2019. Amended Pleadings due by 8/23/2019. Fact Discovery completed by 5/22/2020. Dispositive Motions due by 9/4/2020. Joint Claim Construction Brief due by 3/6/2020. A Markman Hearing is set for 4/6/2020 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 1/25/2021. A Final Pretrial Conference is set for 1/28/2021 at 04:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Jury Trial is set for 2/8/2021 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 7/29/2019. (nmf) |
| Jul 30, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 7/30/2019. (dlb) |
| Jul 25, 2019 | 45 | Proposed Order (20) Docket Text: PROPOSED ORDER Proposed Scheduling Order by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Farnan, Brian) |
| Jul 25, 2019 | 45 | Letter to The Honorable Colm F. Connolly (1) |
| Jul 25, 2019 | 45 | Proposed Order (Main Document) (20) Docket Text: PROPOSED ORDER Proposed Scheduling Order by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Farnan, Brian) |
| Jul 25, 2019 | 45 | Proposed Order (Letter to The Honorable Colm F. Connolly) (1) Docket Text: PROPOSED ORDER Proposed Scheduling Order by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Farnan, Brian) |
| Jul 19, 2019 | 44 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) University of Massachusetts and Carmel Laboratories, LLC's Amended First Set of Interrogatories to Defendant L'Oreal USA, Inc.; (ii) University of Massachusetts and Carmel Laboratories, LLC's Second Set of Interrogatories to Defendant L'Oreal USA, Inc.; and (iii) University of Massachusetts and Carmel Laboratories, LLC's Second Set of Requests for Production of Documents to Defendant L'Oreal USA, Inc. filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jul 18, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 7/18/2019. (Court Reporter V. Gunning.) Counsel to submit the final revised proposed scheduling order to the Court. (nmf) |
| Jul 16, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [42] Proposed Scheduling Order, Having reviewed the parties' proposed scheduling order, IT IS ORDERED that the scheduling conference will be held by telephone. Counsel for plaintiffs shall coordinate and initiate the call to chambers. Order Setting Telephonic Scheduling Conference: A Telephonic Scheduling Conference is set for 7/18/2019 at 10:00 AM before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 7/16/2019. (nmf) |
| Jul 15, 2019 | 42 | Proposed Order (21) Docket Text: PROPOSED ORDER Proposed Scheduling Order by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Farnan, Brian) |
| Jul 15, 2019 | 42 | Letter to The Honorable Colm F. Connolly (1) |
| Jul 15, 2019 | 43 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) University of Massachusetts and Carmel Laboratories, LLC's First Set of Interrogatories to Defendant L'Oreal USA, Inc. and (ii) University of Massachusetts and Carmel Laboratories, LLC's First Set of Requests for Production of Documents to Defendant L'Oreal USA, Inc. filed by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jul 15, 2019 | 42 | Proposed Order (Main Document) (21) Docket Text: PROPOSED ORDER Proposed Scheduling Order by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Farnan, Brian) |
| Jul 15, 2019 | 42 | Proposed Order (Letter to The Honorable Colm F. Connolly) (1) Docket Text: PROPOSED ORDER Proposed Scheduling Order by Carmel Laboratories, LLC, University of Massachusetts. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Farnan, Brian) |
| Jul 3, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Beatrice Franklin for Carmel Laboratories, LLC,University of Massachusetts added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Jul 3, 2019 | 41 | Answer to Counterclaim (6) Docket Text: ANSWER to [38] Answer to Amended Complaint, Counterclaim by Carmel Laboratories, LLC, University of Massachusetts.(Farnan, Brian) |
| Jul 2, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [40] MOTION for Pro Hac Vice Appearance of Attorney Beatrice Franklin filed by University of Massachusetts, Carmel Laboratories, LLC. Signed by Judge Colm F. Connolly on 7/2/2019. (fms) |
| Jul 1, 2019 | 40 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Beatrice Franklin - filed by Carmel Laboratories, LLC, University of Massachusetts. Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Jun 28, 2019 | 39 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 7/18/2019 at 10:00 AM in Chambers before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 6/28/2019. (nmf) |
| Jun 14, 2019 | 38 | Answer to Amended Complaint (17) Docket Text: ANSWER to [13] Amended Complaint, COUNTERCLAIM against Carmel Laboratories, LLC, University of Massachusetts by L'Oreal USA, Inc..(Cottrell, Frederick) Modified on 6/17/2019 (lih). |
| May 30, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [37] STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the complaint to June 14, 2019 filed by L'Oreal USA, Inc. Set/Reset Answer Deadlines: L'Oreal USA, Inc. answer due 6/14/2019. Signed by Judge Colm F. Connolly on 5/30/2019. (fms) |
| May 30, 2019 | 37 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the complaint to June 14, 2019 - filed by L'Oreal USA, Inc.. (Mowery, Katharine) |
| May 17, 2019 | 36 | Memorandum and Order (4) Docket Text: MEMORANDUM ORDER ADOPTING [31] REPORT AND RECOMMENDATIONS granting [23] Motion to Dismiss; denying [15] Motion to Dismiss. Signed by Judge Colm F. Connolly on 5/17/2019. (nmf) |
| Mar 25, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED- re [35] MOTION to Amend/Correct Caption filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. Signed by Judge Sherry R. Fallon on 3/25/2019. (Polito, Rebecca) Modified on 3/27/2019 (lih). |
| Mar 22, 2019 | 35 | Motion to Amend/Correct (3) Docket Text: UNOPPOSED MOTION to Amend/Correct Caption - filed by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) Modified on 3/22/2019 (lih). |
| Mar 22, 2019 | 35 | Exhibit A (9) |
| Mar 22, 2019 | 35 | Exhibit B (11) |
| Mar 22, 2019 | 35 | Exhibit C (6) |
| Mar 22, 2019 | 35 | Exhibit D (6) |
| Mar 22, 2019 | 35 | Text of Proposed Order (1) |
| Mar 22, 2019 | 35 | Motion to Amend/Correct (Main Document) (3) Docket Text: UNOPPOSED MOTION to Amend/Correct Caption - filed by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) Modified on 3/22/2019 (lih). |
| Mar 22, 2019 | 35 | Motion to Amend/Correct (Exhibit A) (9) Docket Text: UNOPPOSED MOTION to Amend/Correct Caption - filed by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) Modified on 3/22/2019 (lih). |
| Mar 22, 2019 | 35 | Motion to Amend/Correct (Exhibit B) (11) Docket Text: UNOPPOSED MOTION to Amend/Correct Caption - filed by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) Modified on 3/22/2019 (lih). |
| Mar 22, 2019 | 35 | Motion to Amend/Correct (Exhibit C) (6) Docket Text: UNOPPOSED MOTION to Amend/Correct Caption - filed by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) Modified on 3/22/2019 (lih). |
| Mar 22, 2019 | 35 | Motion to Amend/Correct (Exhibit D) (6) Docket Text: UNOPPOSED MOTION to Amend/Correct Caption - filed by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) Modified on 3/22/2019 (lih). |
| Mar 22, 2019 | 35 | Motion to Amend/Correct (Text of Proposed Order) (1) Docket Text: UNOPPOSED MOTION to Amend/Correct Caption - filed by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Farnan, Brian) Modified on 3/22/2019 (lih). |
| Dec 11, 2018 | 34 | Response to Objections (13) Docket Text: RESPONSE TO OBJECTIONS by L'Oreal S.A. re [32] Objection to Report and Recommendations . (Cottrell, Frederick) |
| Nov 27, 2018 | 32 | Objection to Report and Recommendations (6) Docket Text: OBJECTION to [31] Report and Recommendations by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Farnan, Brian) |
| Nov 27, 2018 | 33 | Statement (2) Docket Text: Certification Pursuant to the Standing Order for Objections Filed under Fed. R. Civ. P. 72 re [32] Objection to Report and Recommendations by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Farnan, Brian) Modified on 11/28/2018 (lih). |
| Nov 13, 2018 | 31 | Report and Recommendations (26) Docket Text: REPORT AND RECOMMENDATIONS- re [15] MOTION to Dismiss, [23] MOTION to Dismiss. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 11/27/2018. Signed by Judge Sherry R. Fallon on 11/13/2018. (lih) |
| Sep 14, 2018 | N/A | Remark (0) Docket Text: Remark: The text of the 9/12/2018 oral order has been modified to reflect the fact that this case has not yet been referred for ADR. (nmf) |
| Sep 12, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER by Judge Colm F. Connolly on 9/12/2018: The Court HEREBY ORDERS that the referral to Magistrate Judge Sherry R. Fallon shall remain in effect, and this case therefore remains referred to Judge Fallon for discovery and all motions to dismiss, amend, transfer and any discovery motions permitted by the Magistrate Judge, subject to 28 U.S.C. § 636(b) and any further Order of the Court. (nmf) Modified on 9/14/2018 (nmf). |
| Aug 27, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Jul 9, 2018 | 30 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Jason James Rawnsley on behalf of L'Oreal S.A., L'Oreal USA, Inc. (Rawnsley, Jason) |
| Jan 5, 2018 | 29 | Reply Brief (16) Docket Text: REPLY BRIEF re [23] MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by L'Oreal S.A.. (Mowery, Katharine) Modified on 1/9/2018 (lih). |
| Dec 8, 2017 | 27 | Answering Brief in Opposition (27) Docket Text: ANSWERING BRIEF in Opposition re [23] MOTION to Dismiss filed by Carmel Laboratories, LLC, University of Massachusetts Medical School.Reply Brief due date per Local Rules is 12/15/2017. (Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (4) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Exhibit 1 (10) |
| Dec 8, 2017 | 28 | Exhibit 2 (9) |
| Dec 8, 2017 | 28 | Exhibit 3 (3) |
| Dec 8, 2017 | 28 | Exhibit 4 (61) |
| Dec 8, 2017 | 28 | Exhibit 5 (5) |
| Dec 8, 2017 | 28 | Exhibit 6 (361) |
| Dec 8, 2017 | 28 | Exhibit 7 (4) |
| Dec 8, 2017 | 28 | Exhibit 8 (3) |
| Dec 8, 2017 | 28 | Exhibit 9 (5) |
| Dec 8, 2017 | 28 | Exhibit 10 (9) |
| Dec 8, 2017 | 28 | Exhibit 11 (4) |
| Dec 8, 2017 | 28 | Exhibit 12 (8) |
| Dec 8, 2017 | 28 | Exhibit 13 (6) |
| Dec 8, 2017 | 28 | Exhibit 14 (11) |
| Dec 8, 2017 | 28 | Exhibit 15 (4) |
| Dec 8, 2017 | 28 | Exhibit 16 (4) |
| Dec 8, 2017 | 28 | Exhibit 17 (8) |
| Dec 8, 2017 | 28 | Exhibit 18 (27) |
| Dec 8, 2017 | 28 | Exhibit 19 (24) |
| Dec 8, 2017 | 28 | Exhibit 20 (3) |
| Dec 8, 2017 | 28 | Exhibit 21 (12) |
| Dec 8, 2017 | 28 | Exhibit 22 (9) |
| Dec 8, 2017 | 28 | Exhibit 23 (27) |
| Dec 8, 2017 | 28 | Exhibit 24 (2) |
| Dec 8, 2017 | 28 | Exhibit 25 (3) |
| Dec 8, 2017 | 28 | Exhibit 26 (23) |
| Dec 8, 2017 | 28 | Declaration (Main Document) (4) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 1) (10) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 2) (9) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 3) (3) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 4) (30) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 5) (5) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 6) (30) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 7) (4) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 8) (3) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 9) (5) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 10) (9) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 11) (4) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 12) (8) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 13) (6) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 14) (11) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 15) (4) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 16) (4) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 17) (8) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 18) (27) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 19) (24) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 20) (3) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 21) (12) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 22) (9) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 23) (27) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 24) (2) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 25) (3) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Dec 8, 2017 | 28 | Declaration (Exhibit 26) (23) Docket Text: DECLARATION of Michael J. Farnan re [27] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26)(Farnan, Brian) Modified on 12/8/2017 (lih). |
| Oct 27, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED- re [26] STIPULATION TO EXTEND TIME. Set Briefing Schedule: re [23] MOTION to Dismiss. (Answering Brief due 12/8/2017., Reply Brief due 1/5/2018.) Signed by Judge Sherry R. Fallon on 10/27/2017. (lih) |
| Oct 26, 2017 | 26 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME (i) for Plaintiffs to file its Answering Brief to Defendant L'Oreal S.A.'s Motion to Dismiss and (ii) for L'Oreal S.A. to file its Reply in Support to (i) 12/8/2017 and (ii) 1/5/2018 - filed by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Farnan, Brian) |
| Oct 16, 2017 | 23 | Motion to Dismiss/Lack of Personal Jurisdiction (2) Docket Text: MOTION to Dismiss for Lack of Jurisdiction Over the Person and for Failure to State a Claim - filed by L'Oreal S.A.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Cottrell, Frederick) Modified on 10/17/2017 (lih). |
| Oct 16, 2017 | 23 | Text of Proposed Order (1) |
| Oct 16, 2017 | 24 | Opening Brief in Support (25) Docket Text: OPENING BRIEF in Support re [23] MOTION to Dismiss for Lack of Jurisdiction Over the Person and for Failure to State a Claim filed by L'Oreal S.A..Answering Brief/Response due date per Local Rules is 10/30/2017. (Cottrell, Frederick) Modified on 10/17/2017 (lih). |
| Oct 16, 2017 | 25 | Declaration (4) Docket Text: DECLARATION of Roy Rabinowitz [24] Opening Brief in Support by L'Oreal S.A.. (Cottrell, Frederick) Modified on 10/17/2017 (lih). |
| Oct 16, 2017 | 23 | Motion to Dismiss/Lack of Personal Jurisdiction (Main Document) (2) Docket Text: MOTION to Dismiss for Lack of Jurisdiction Over the Person and for Failure to State a Claim - filed by L'Oreal S.A.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Cottrell, Frederick) Modified on 10/17/2017 (lih). |
| Oct 16, 2017 | 23 | Motion to Dismiss/Lack of Personal Jurisdiction (Text of Proposed Order) (1) Docket Text: MOTION to Dismiss for Lack of Jurisdiction Over the Person and for Failure to State a Claim - filed by L'Oreal S.A.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Cottrell, Frederick) Modified on 10/17/2017 (lih). |
| Oct 2, 2017 | 22 | Reply Brief (15) Docket Text: REPLY BRIEF re [15] MOTION to Dismiss for Failure to State a Claim filed by L'Oreal USA, Inc.. (Mowery, Katharine) Modified on 10/3/2017 (lih). |
| Sep 8, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED- re [21] STIPULATION TO EXTEND TIME. Set Briefing Schedule: re [15] MOTION to Dismiss for Failure to State a Claim. (Reply Brief due 10/2/2017.) Signed by Judge Sherry R. Fallon on 9/8/2017. (lih) |
| Sep 6, 2017 | 21 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to File L'Oreal USA, Inc.'s Reply Brief in Support of Its Motion to Dismiss to October 2, 2017 - filed by L'Oreal S.A., L'Oreal USA, Inc.. (Mowery, Katharine) |
| Sep 5, 2017 | 19 | Answering Brief in Opposition (22) Docket Text: ANSWERING BRIEF in Opposition re [15] MOTION to Dismiss for Failure to State a Claim filed by Carmel Laboratories, LLC, University of Massachusetts Medical School.Reply Brief due date per Local Rules is 9/12/2017. (Farnan, Brian) |
| Sep 5, 2017 | 20 | Declaration (1) Docket Text: DECLARATION of Brian E. Farnan re [19] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Farnan, Brian) Modified on 9/6/2017 (lih). |
| Sep 5, 2017 | 20 | Exhibit A (17) |
| Sep 5, 2017 | 20 | Exhibit B (42) |
| Sep 5, 2017 | 20 | Declaration (Main Document) (1) Docket Text: DECLARATION of Brian E. Farnan re [19] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Farnan, Brian) Modified on 9/6/2017 (lih). |
| Sep 5, 2017 | 20 | Declaration (Exhibit A) (17) Docket Text: DECLARATION of Brian E. Farnan re [19] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Farnan, Brian) Modified on 9/6/2017 (lih). |
| Sep 5, 2017 | 20 | Declaration (Exhibit B) (30) Docket Text: DECLARATION of Brian E. Farnan re [19] Answering Brief in Opposition by Carmel Laboratories, LLC, University of Massachusetts Medical School. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Farnan, Brian) Modified on 9/6/2017 (lih). |
| Aug 23, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED- re [14] Stipulation. Set/Reset Answer Deadlines: L'Oreal S.A. answer due 10/16/2017. Signed by Judge Sherry R. Fallon on 8/23/2017. (lih) |
| Aug 23, 2017 | 15 | Motion to Dismiss for Failure to State a Claim (2) Docket Text: MOTION to Dismiss for Failure to State a Claim - filed by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Cottrell, Frederick) |
| Aug 23, 2017 | 15 | Text of Proposed Order (1) |
| Aug 23, 2017 | 16 | Opening Brief in Support (20) Docket Text: OPENING BRIEF in Support re [15] MOTION to Dismiss for Failure to State a Claim filed by L'Oreal USA, Inc..Answering Brief/Response due date per Local Rules is 9/6/2017. (Cottrell, Frederick) |
| Aug 23, 2017 | 17 | Declaration (3) Docket Text: DECLARATION of Katherine F. Murray re [15] MOTION to Dismiss for Failure to State a Claim by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-D)(Cottrell, Frederick) Modified on 8/24/2017 (lih). |
| Aug 23, 2017 | 17 | Exhibit A-D (27) |
| Aug 23, 2017 | 18 | Statement (4) Docket Text: Request for Judicial Notice re [16] Opening Brief in Support by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-B)(Cottrell, Frederick) Modified on 8/24/2017 (lih). |
| Aug 23, 2017 | 18 | Exhibit A-B (15) |
| Aug 23, 2017 | 15 | Motion to Dismiss for Failure to State a Claim (Main Document) (2) Docket Text: MOTION to Dismiss for Failure to State a Claim - filed by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Cottrell, Frederick) |
| Aug 23, 2017 | 15 | Motion to Dismiss for Failure to State a Claim (Text of Proposed Order) (1) Docket Text: MOTION to Dismiss for Failure to State a Claim - filed by L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Cottrell, Frederick) |
| Aug 23, 2017 | 17 | Declaration (Main Document) (3) Docket Text: DECLARATION of Katherine F. Murray re [15] MOTION to Dismiss for Failure to State a Claim by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-D)(Cottrell, Frederick) Modified on 8/24/2017 (lih). |
| Aug 23, 2017 | 17 | Declaration (Exhibit A-D) (27) Docket Text: DECLARATION of Katherine F. Murray re [15] MOTION to Dismiss for Failure to State a Claim by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-D)(Cottrell, Frederick) Modified on 8/24/2017 (lih). |
| Aug 23, 2017 | 18 | Statement (Main Document) (4) Docket Text: Request for Judicial Notice re [16] Opening Brief in Support by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-B)(Cottrell, Frederick) Modified on 8/24/2017 (lih). |
| Aug 23, 2017 | 18 | Statement (Exhibit A-B) (15) Docket Text: Request for Judicial Notice re [16] Opening Brief in Support by L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A-B)(Cottrell, Frederick) Modified on 8/24/2017 (lih). |
| Aug 22, 2017 | 14 | Stipulation (2) Docket Text: STIPULATION and Order to Set Deadline for L'Oreal S.A. to Respond to the Amended Complaint by L'Oreal S.A., L'Oreal USA, Inc.. (Mowery, Katharine) |
| Aug 18, 2017 | 13 | Amended Complaint (14) Docket Text: First AMENDED COMPLAINT against L'Oreal S.A., L'Oreal USA, Inc.- filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Farnan, Brian) |
| Aug 18, 2017 | 13 | Exhibit 1 (9) |
| Aug 18, 2017 | 13 | Exhibit 2 (11) |
| Aug 18, 2017 | 13 | Exhibit 3 (8) |
| Aug 18, 2017 | 13 | Exhibit 4 (19) |
| Aug 18, 2017 | 13 | Exhibit 5 (3) |
| Aug 18, 2017 | 13 | Exhibit 6 (7) |
| Aug 18, 2017 | 13 | Exhibit 7 (11) |
| Aug 18, 2017 | 13 | Exhibit 8 (7) |
| Aug 18, 2017 | 13 | Exhibit 9 (9) |
| Aug 18, 2017 | 13 | Exhibit 10 (9) |
| Aug 18, 2017 | 13 | Exhibit 11 (2) |
| Aug 18, 2017 | 13 | Exhibit 12 (12) |
| Aug 18, 2017 | 13 | Amended Complaint* (1) |
| Aug 18, 2017 | 13 | Amended Complaint (Main Document) (14) Docket Text: First AMENDED COMPLAINT against L'Oreal S.A., L'Oreal USA, Inc.- filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Farnan, Brian) |
| Aug 18, 2017 | 13 | Amended Complaint (Exhibit 1) (9) Docket Text: First AMENDED COMPLAINT against L'Oreal S.A., L'Oreal USA, Inc.- filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Farnan, Brian) |
| Aug 18, 2017 | 13 | Amended Complaint (Exhibit 2) (11) Docket Text: First AMENDED COMPLAINT against L'Oreal S.A., L'Oreal USA, Inc.- filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Farnan, Brian) |
| Aug 18, 2017 | 13 | Amended Complaint (Exhibit 3) (8) Docket Text: First AMENDED COMPLAINT against L'Oreal S.A., L'Oreal USA, Inc.- filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Farnan, Brian) |
| Aug 18, 2017 | 13 | Amended Complaint (Exhibit 4) (19) Docket Text: First AMENDED COMPLAINT against L'Oreal S.A., L'Oreal USA, Inc.- filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Farnan, Brian) |
| Aug 18, 2017 | 13 | Amended Complaint (Exhibit 5) (3) Docket Text: First AMENDED COMPLAINT against L'Oreal S.A., L'Oreal USA, Inc.- filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Farnan, Brian) |
| Aug 18, 2017 | 13 | Amended Complaint (Exhibit 6) (7) Docket Text: First AMENDED COMPLAINT against L'Oreal S.A., L'Oreal USA, Inc.- filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Farnan, Brian) |
| Aug 18, 2017 | 13 | Amended Complaint (Exhibit 7) (11) Docket Text: First AMENDED COMPLAINT against L'Oreal S.A., L'Oreal USA, Inc.- filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Farnan, Brian) |
| Aug 18, 2017 | 13 | Amended Complaint (Exhibit 8) (7) Docket Text: First AMENDED COMPLAINT against L'Oreal S.A., L'Oreal USA, Inc.- filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Farnan, Brian) |
| Aug 18, 2017 | 13 | Amended Complaint (Exhibit 9) (9) Docket Text: First AMENDED COMPLAINT against L'Oreal S.A., L'Oreal USA, Inc.- filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Farnan, Brian) |
| Aug 18, 2017 | 13 | Amended Complaint (Exhibit 10) (9) Docket Text: First AMENDED COMPLAINT against L'Oreal S.A., L'Oreal USA, Inc.- filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Farnan, Brian) |
| Aug 18, 2017 | 13 | Amended Complaint (Exhibit 11) (2) Docket Text: First AMENDED COMPLAINT against L'Oreal S.A., L'Oreal USA, Inc.- filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Farnan, Brian) |
| Aug 18, 2017 | 13 | Amended Complaint (Exhibit 12) (12) Docket Text: First AMENDED COMPLAINT against L'Oreal S.A., L'Oreal USA, Inc.- filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12)(Farnan, Brian) |
| Aug 15, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED- re [12] MOTION for Pro Hac Vice Appearance of Attorney Dennis S. Ellis. Signed by Judge Sherry R. Fallon on 8/15/2017. (lih) |
| Aug 15, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Naveen Modi for L'Oreal S.A. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) |
| Aug 14, 2017 | 12 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dennis S. Ellis - filed by L'Oreal S.A., L'Oreal USA, Inc.. (Attachments: # (1) Certification of Dennis Ellis)Motions referred to Sherry R. Fallon.(Cottrell, Frederick) |
| Aug 14, 2017 | 12 | Certification of Dennis Ellis (1) |
| Aug 14, 2017 | 12 | Motion for Leave to Appear Pro Hac Vice (Main Document) (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dennis S. Ellis - filed by L'Oreal S.A., L'Oreal USA, Inc.. (Attachments: # (1) Certification of Dennis Ellis)Motions referred to Sherry R. Fallon.(Cottrell, Frederick) |
| Aug 14, 2017 | 12 | Motion for Leave to Appear Pro Hac Vice (Certification of Dennis Ellis) (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dennis S. Ellis - filed by L'Oreal S.A., L'Oreal USA, Inc.. (Attachments: # (1) Certification of Dennis Ellis)Motions referred to Sherry R. Fallon.(Cottrell, Frederick) |
| Aug 11, 2017 | N/A | Oral Order (0) Docket Text: ORAL ORDER - Pursuant to the filing of this case, the Court issues the following order: This case shall be immediately referred to Magistrate Judge Sherry R. Fallon. Magistrate Judge Fallon shall issue a scheduling order when appropriate. Magistrate Judge Fallon shall handle all dispositive and nondispositive matters on all issues, including claim construction, except for summary judgments, Daubert motions and pretrial motions in limine. On all dispositive matters, the magistrate judge shall issue a report and recommendation. The parties have the right to file objections to the report and recommendation, or in the case of nondispositive matters, file an appeal of the magistrate judge's order, and the same shall be decided by the undersigned. The magistrate judge shall likewise handle all discovery matters, scheduling, and pretrial conferences. If the parties believe the magistrate judge has a conflict of interest with this case, the parties shall so notify the Court. IT IS SO ORDERED. Signed by Judge Joseph F. Bataillon on 8/11/2017. (Brunswick, Amy) |
| Aug 9, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Blaine M. Hackman,Joseph E. Palys,Katherine F. Murray for L'Oreal S.A.,Blaine M. Hackman,Joseph E. Palys,Katherine F. Murray for L'Oreal USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Aug 9, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Joseph F. Bataillon of the District of Nebraska (in lieu of Vacant Judgeship). Please include the initials of the Judge (JFB) after the case number on all documents filed. (rjb) |
| Aug 8, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney William Christopher Carmody for University of Massachusetts Medical School added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Aug 8, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Tamar E. Lusztig for University of Massachusetts Medical School added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Aug 8, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Justin A. Nelson for University of Massachusetts Medical School added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Aug 7, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED- re [5] MOTION for Pro Hac Vice Appearance of Attorney Murray, Katherine F.; Modi, Naveen; Palys, Joseph E.; Hackman, Blaine M., [6] MOTION for Pro Hac Vice Appearance of Attorney William Christopher Carmody, Justin A. Nelson, and Tamar E. Lusztig. Signed by Judge Sherry R. Fallon on 8/7/2017. (lih) |
| Aug 4, 2017 | 5 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Murray, Katherine F.; Modi, Naveen; Palys, Joseph E.; Hackman, Blaine M. - filed by L'Oreal S.A., L'Oreal USA, Inc.. Motions referred to Sherry R. Fallon.(Cottrell, Frederick) |
| Aug 4, 2017 | 6 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William Christopher Carmody, Justin A. Nelson, and Tamar E. Lusztig - filed by Carmel Laboratories, LLC, University of Massachusetts Medical School. Motions referred to Sherry R. Fallon.(Farnan, Brian) |
| Aug 4, 2017 | 7 | Motion to Dismiss for Failure to State a Claim (2) Docket Text: MOTION to Dismiss for Failure to State a Claim - filed by L'Oreal S.A., L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Cottrell, Frederick) |
| Aug 4, 2017 | 7 | Text of Proposed Order (1) |
| Aug 4, 2017 | 8 | Opening Brief in Support (18) Docket Text: OPENING BRIEF in Support re [7] MOTION to Dismiss for Failure to State a Claim filed by L'Oreal S.A., L'Oreal USA, Inc..Answering Brief/Response due date per Local Rules is 8/18/2017. (Cottrell, Frederick) |
| Aug 4, 2017 | 9 | Declaration (3) Docket Text: DECLARATIONof Katherine F. Murray re [7] MOTION to Dismiss for Failure to State a Claim by L'Oreal S.A., L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Cottrell, Frederick) Modified on 8/7/2017 (lih). |
| Aug 4, 2017 | 9 | Exhibit A (3) |
| Aug 4, 2017 | 9 | Exhibit B (3) |
| Aug 4, 2017 | 9 | Exhibit C (6) |
| Aug 4, 2017 | 10 | Statement (4) Docket Text: STATEMENT re [7] MOTION to Dismiss for Failure to State a Claim by L'Oreal S.A., L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Cottrell, Frederick) |
| Aug 4, 2017 | 10 | Exhibit A (9) |
| Aug 4, 2017 | 10 | Exhibit B (6) |
| Aug 4, 2017 | 7 | Motion to Dismiss for Failure to State a Claim (Main Document) (2) Docket Text: MOTION to Dismiss for Failure to State a Claim - filed by L'Oreal S.A., L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Cottrell, Frederick) |
| Aug 4, 2017 | 7 | Motion to Dismiss for Failure to State a Claim (Text of Proposed Order) (1) Docket Text: MOTION to Dismiss for Failure to State a Claim - filed by L'Oreal S.A., L'Oreal USA, Inc.. (Attachments: # (1) Text of Proposed Order)Motions referred to Sherry R. Fallon.(Cottrell, Frederick) |
| Aug 4, 2017 | 9 | Declaration (Main Document) (3) Docket Text: DECLARATIONof Katherine F. Murray re [7] MOTION to Dismiss for Failure to State a Claim by L'Oreal S.A., L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Cottrell, Frederick) Modified on 8/7/2017 (lih). |
| Aug 4, 2017 | 9 | Declaration (Exhibit A) (3) Docket Text: DECLARATIONof Katherine F. Murray re [7] MOTION to Dismiss for Failure to State a Claim by L'Oreal S.A., L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Cottrell, Frederick) Modified on 8/7/2017 (lih). |
| Aug 4, 2017 | 9 | Declaration (Exhibit B) (3) Docket Text: DECLARATIONof Katherine F. Murray re [7] MOTION to Dismiss for Failure to State a Claim by L'Oreal S.A., L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Cottrell, Frederick) Modified on 8/7/2017 (lih). |
| Aug 4, 2017 | 9 | Declaration (Exhibit C) (6) Docket Text: DECLARATIONof Katherine F. Murray re [7] MOTION to Dismiss for Failure to State a Claim by L'Oreal S.A., L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Cottrell, Frederick) Modified on 8/7/2017 (lih). |
| Aug 4, 2017 | 10 | Statement (Main Document) (4) Docket Text: STATEMENT re [7] MOTION to Dismiss for Failure to State a Claim by L'Oreal S.A., L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Cottrell, Frederick) |
| Aug 4, 2017 | 10 | Statement (Exhibit A) (9) Docket Text: STATEMENT re [7] MOTION to Dismiss for Failure to State a Claim by L'Oreal S.A., L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Cottrell, Frederick) |
| Aug 4, 2017 | 10 | Statement (Exhibit B) (6) Docket Text: STATEMENT re [7] MOTION to Dismiss for Failure to State a Claim by L'Oreal S.A., L'Oreal USA, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Cottrell, Frederick) |
| Jul 21, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED- re [4] Stipulation. Set/Reset Answer Deadlines: L'Oreal S.A. answer due 10/16/2017; L'Oreal USA, Inc. answer due 8/4/2017. Signed by Judge Sherry R. Fallon on 7/21/2017. (lih) |
| Jul 19, 2017 | 4 | Stipulation (2) Docket Text: STIPULATION to Extend Deadlines for Responses to the Complaint by L'Oreal S.A., L'Oreal USA, Inc.. (Cottrell, Frederick) Modified on 7/20/2017 (lih). |
| Jul 7, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to L'Oreal S.A. on 7/7/2017. (ceg) |
| Jul 5, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Vacant Judgeship (2017). Please include initials of VAC after the case number on all documents filed. (rjb) |
| Jul 5, 2017 | N/A | Case Referred to Magistrate Judge (0) Docket Text: CASE REFERRED to Magistrate Judge Sherry R. Fallon. (This matter has been assigned to the Vacant Judgeship and referred to a Magistrate Judge for handling through case-dispositive motions. The Magistrate Judge has full authority permitted by law to manage this matter, including entering schedules through trial, deciding non-dispositive matters and making recommendations as to the resolution of dispositive matters. Litigants and counsel are reminded that they have the option of consenting to the Magistrate Judge to handle the case in full, including trial, or consenting to having a particular motion resolved by the Magistrate Judge.) (rjb) |
| Jun 30, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to L'Oreal USA, Inc. on 6/30/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (jcs) |
| Jun 30, 2017 | 1 | Exhibit 1 (9) |
| Jun 30, 2017 | 1 | Exhibit 2 (11) |
| Jun 30, 2017 | 1 | Exhibit 3 (8) |
| Jun 30, 2017 | 1 | Exhibit 4 (19) |
| Jun 30, 2017 | 1 | Exhibit 5 (3) |
| Jun 30, 2017 | 1 | Exhibit 6 (7) |
| Jun 30, 2017 | 1 | Exhibit 7 (11) |
| Jun 30, 2017 | 1 | Exhibit 8 (7) |
| Jun 30, 2017 | 1 | Exhibit 9 (9) |
| Jun 30, 2017 | 1 | Exhibit 10 (9) |
| Jun 30, 2017 | 1 | Exhibit 11 (2) |
| Jun 30, 2017 | 1 | Exhibit 12 (12) |
| Jun 30, 2017 | 1 | Civil Cover Sheet (1) |
| Jun 30, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) |
| Jun 30, 2017 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,423,327 B1; US 6,645,513 B2. (jcs) |
| Jun 30, 2017 | 1 | Complaint* (1) |
| Jun 30, 2017 | 1 | Complaint (Main Document) (14) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against L'Oreal S.A., L'Oreal USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2175078.) - filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Civil Cover Sheet)(jcs) |
| Jun 30, 2017 | 1 | Complaint (Exhibit 1) (9) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against L'Oreal S.A., L'Oreal USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2175078.) - filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Civil Cover Sheet)(jcs) |
| Jun 30, 2017 | 1 | Complaint (Exhibit 2) (11) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against L'Oreal S.A., L'Oreal USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2175078.) - filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Civil Cover Sheet)(jcs) |
| Jun 30, 2017 | 1 | Complaint (Exhibit 3) (8) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against L'Oreal S.A., L'Oreal USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2175078.) - filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Civil Cover Sheet)(jcs) |
| Jun 30, 2017 | 1 | Complaint (Exhibit 4) (19) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against L'Oreal S.A., L'Oreal USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2175078.) - filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Civil Cover Sheet)(jcs) |
| Jun 30, 2017 | 1 | Complaint (Exhibit 5) (3) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against L'Oreal S.A., L'Oreal USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2175078.) - filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Civil Cover Sheet)(jcs) |
| Jun 30, 2017 | 1 | Complaint (Exhibit 6) (7) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against L'Oreal S.A., L'Oreal USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2175078.) - filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Civil Cover Sheet)(jcs) |
| Jun 30, 2017 | 1 | Complaint (Exhibit 7) (11) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against L'Oreal S.A., L'Oreal USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2175078.) - filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Civil Cover Sheet)(jcs) |
| Jun 30, 2017 | 1 | Complaint (Exhibit 8) (7) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against L'Oreal S.A., L'Oreal USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2175078.) - filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Civil Cover Sheet)(jcs) |
| Jun 30, 2017 | 1 | Complaint (Exhibit 9) (9) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against L'Oreal S.A., L'Oreal USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2175078.) - filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Civil Cover Sheet)(jcs) |
| Jun 30, 2017 | 1 | Complaint (Exhibit 10) (9) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against L'Oreal S.A., L'Oreal USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2175078.) - filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Civil Cover Sheet)(jcs) |
| Jun 30, 2017 | 1 | Complaint (Exhibit 11) (2) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against L'Oreal S.A., L'Oreal USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2175078.) - filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Civil Cover Sheet)(jcs) |
| Jun 30, 2017 | 1 | Complaint (Exhibit 12) (12) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against L'Oreal S.A., L'Oreal USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2175078.) - filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Civil Cover Sheet)(jcs) |
| Jun 30, 2017 | 1 | Complaint (Civil Cover Sheet) (1) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against L'Oreal S.A., L'Oreal USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2175078.) - filed by University of Massachusetts Medical School, Carmel Laboratories, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Civil Cover Sheet)(jcs) |
